General Information of Drug (ID: DM6Y3A0)

Drug Name
GALLICACID Drug Info
Synonyms
Gallic acid; 3,4,5-Trihydroxybenzoic acid; 149-91-7; gallate; Benzoic acid, 3,4,5-trihydroxy-; Gallic acid, tech.; GALOP; Pyrogallol-5-carboxylic acid; Kyselina gallova; HSDB 2117; 3,4,5-Trihydroxybenzoate; CCRIS 5523; Kyselina gallova [Czech]; Gallic acid polymer; UNII-632XD903SP; NSC 674319; Gallicum acidum; CHEBI:30778; AI3-16412; Kyselina 3,4,5-trihydroxybenzoova; EINECS 205-749-9; NSC 20103; BRN 2050274; GALLIC ACID ANHYDROUS; Kyselina 3,4,5-trihydroxybenzoova [Czech]; CHEMBL288114; LNTHITQWFMADLM-UHFFFAOYSA-N; 632XD903SP
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
370
ChEBI ID
CHEMBL288114
CAS Number
CAS 149-91-7
TTD Drug ID
DM6Y3A0

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
DOT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Patented Agent(s)
Discontinued Drug(s)
Investigative Drug(s)
Preclinical Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Salicyclic acid DM2F8XZ Acne vulgaris ED80 Approved [5]
Sulfamylon DMIO1K0 Bacterial infection 1A00-1C4Z Approved [6]
Curcumin DMQPH29 Solid tumour/cancer 2A00-2F9Z Phase 3 [7]
PARABEN DMEW5Z8 N. A. N. A. Phase 3 [2]
Coumate DMVKW0N Breast cancer 2C60-2C65 Phase 2 [8]
SAR566658 DM6Q295 Solid tumour/cancer 2A00-2F9Z Phase 2 [9]
FERULIC ACID DMJC7NF Discovery agent N.A. Patented [2]
SPERMINE DMD4BFY N. A. N. A. Terminated [10]
ELLAGIC ACID DMX8BS5 Discovery agent N.A. Investigative [2]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [11]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Targeting P-selectin (SELP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Crizanlizumab DMAHOVJ Vaso-occlusive crisis BE2Y Approved [12]
GMI-1070 DMJ432G Asthma CA23 Phase 3 [13]
Inclacumab DMXV94M Sickle-cell disorder 3A51 Phase 3 [14]
CY-1503 DML906E Hypertension BA00-BA04 Phase 2/3 [15]
BAICALEIN DM4C7E6 Influenza virus infection 1E30-1E32 Phase 2 [3]
SelG1 DMTQ2K0 Vaso-occlusive crisis BE2Y Phase 2 [16]
RPSGL-Ig DM0BFJ5 Delayed graft function 4B24.0 Phase 2 [17]
PSI-697 DM75FWO Atherosclerosis BD40 Phase 1 [18]
CDP-850 DMWHQM3 Solid tumour/cancer 2A00-2F9Z Discontinued in Phase 2 [19]
CY-1787 DMWY2NT Allergy 4A80-4A85 Discontinued in Phase 1 [20]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Targeting Carbonic anhydrase I (CA-I)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Salicyclic acid DM2F8XZ Acne vulgaris ED80 Approved [5]
Ethoxzolamide DMVO4ED Glaucoma/ocular hypertension 9C61 Approved [21]
Dichlorphenamide DMH7IDQ Chronic glaucoma 9C61.0Z Approved [21]
Methazolamide DM7J2TA Glaucoma/ocular hypertension 9C61 Approved [22]
Acetazolamide DM1AF5U Absence epilepsy Approved [21]
Curcumin DMQPH29 Solid tumour/cancer 2A00-2F9Z Phase 3 [7]
PARABEN DMEW5Z8 N. A. N. A. Phase 3 [2]
CG-100649 DMIKMA9 Arthritis FA20 Phase 3 [23]
PHENOL DM1QSM3 N. A. N. A. Phase 2/3 [7]
Coumate DMVKW0N Breast cancer 2C60-2C65 Phase 2 [8]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Salicyclic acid DM2F8XZ Acne vulgaris ED80 Approved [5]
Sulfamylon DMIO1K0 Bacterial infection 1A00-1C4Z Approved [24]
Curcumin DMQPH29 Solid tumour/cancer 2A00-2F9Z Phase 3 [7]
PARABEN DMEW5Z8 N. A. N. A. Phase 3 [2]
PHENOL DM1QSM3 N. A. N. A. Phase 2/3 [7]
Coumate DMVKW0N Breast cancer 2C60-2C65 Phase 2 [8]
FERULIC ACID DMJC7NF Discovery agent N.A. Patented [2]
ELLAGIC ACID DMX8BS5 Discovery agent N.A. Investigative [2]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [11]
CATECHIN DMY38SB Discovery agent N.A. Investigative [7]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Salicyclic acid DM2F8XZ Acne vulgaris ED80 Approved [5]
Sulfamylon DMIO1K0 Bacterial infection 1A00-1C4Z Approved [24]
Dorzolamide DMA17D0 Ocular hypertension 9C61.01 Approved [25]
Chlorothiazide DMLHESP Chronic heart failure BD1Z Approved [26]
Ethoxzolamide DMVO4ED Glaucoma/ocular hypertension 9C61 Approved [27]
Dichlorphenamide DMH7IDQ Chronic glaucoma 9C61.0Z Approved [27]
Cyclothiazide DMJ4AWC Congestive heart failure BD10 Approved [28]
Ethinamate DMK57GB Insomnia 7A00-7A0Z Approved [29]
Benzthiazide DMQWZ0H High blood pressure BA00 Approved [30]
Curcumin DMQPH29 Solid tumour/cancer 2A00-2F9Z Phase 3 [7]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sulfamylon DMIO1K0 Bacterial infection 1A00-1C4Z Approved [31]
TRIENTINE DMD2WPG Inborn error of metabolism 5C50-5C59 Approved [10]
Curcumin DMQPH29 Solid tumour/cancer 2A00-2F9Z Phase 3 [7]
PARABEN DMEW5Z8 N. A. N. A. Phase 3 [2]
PHENOL DM1QSM3 N. A. N. A. Phase 2/3 [7]
Coumate DMVKW0N Breast cancer 2C60-2C65 Phase 2 [8]
FERULIC ACID DMJC7NF Discovery agent N.A. Patented [2]
SPERMINE DMD4BFY N. A. N. A. Terminated [10]
ELLAGIC ACID DMX8BS5 Discovery agent N.A. Investigative [2]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [11]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Targeting Carbonic anhydrase (CA)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Salicyclic acid DM2F8XZ Acne vulgaris ED80 Approved [32]
Sulfamylon DMIO1K0 Bacterial infection 1A00-1C4Z Approved [6]
Quinethazone DMWCOSR Hypertension BA00-BA04 Approved [33]
Curcumin DMQPH29 Solid tumour/cancer 2A00-2F9Z Phase 3 [7]
PARABEN DMEW5Z8 N. A. N. A. Phase 3 [2]
PHENOL DM1QSM3 N. A. N. A. Phase 2/3 [7]
Coumate DMVKW0N Breast cancer 2C60-2C65 Phase 2 [8]
SULFAMIDE DMMAS3K N. A. N. A. Phase 1 [34]
FERULIC ACID DMJC7NF Discovery agent N.A. Patented [2]
PMID30074415-Compound-21 DM3NPOU N. A. N. A. Patented [35]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Salicyclic acid DM2F8XZ Acne vulgaris ED80 Approved [5]
Sulfamylon DMIO1K0 Bacterial infection 1A00-1C4Z Approved [36]
Brinzolamide DMBAPFG Ocular hypertension 9C61.01 Approved [21]
Curcumin DMQPH29 Solid tumour/cancer 2A00-2F9Z Phase 3 [7]
PARABEN DMEW5Z8 N. A. N. A. Phase 3 [2]
PHENOL DM1QSM3 N. A. N. A. Phase 2/3 [7]
Coumate DMVKW0N Breast cancer 2C60-2C65 Phase 2 [8]
Sodium pyruvate DMST6A3 Asthma CA23 Phase 1/2 [37]
SULFAMIDE DMMAS3K N. A. N. A. Phase 1 [34]
FERULIC ACID DMJC7NF Discovery agent N.A. Patented [2]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Curcumin DMQPH29 Solid tumour/cancer 2A00-2F9Z Phase 3 [7]
PARABEN DMEW5Z8 N. A. N. A. Phase 3 [2]
PHENOL DM1QSM3 N. A. N. A. Phase 2/3 [7]
Coumate DMVKW0N Breast cancer 2C60-2C65 Phase 2 [8]
INDISULAM DM9SX6Y Lymphoma 2A80-2A86 Phase 2 [38]
Girentuximab I-124 DMG3O2Z Renal cell carcinoma 2C90 Phase 2 [39]
SULFAMIDE DMMAS3K N. A. N. A. Phase 1 [40]
BAY 79-4620 DM14XQN Solid tumour/cancer 2A00-2F9Z Phase 1 [41]
90Y-cG250 DMJR6TC Solid tumour/cancer 2A00-2F9Z Phase 1 [42]
FERULIC ACID DMJC7NF Discovery agent N.A. Patented [2]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [43]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [44]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [45]
Gefitinib DM15F0X Colon adenocarcinoma Approved [46]
Talazoparib DM1KS78 Breast cancer 2C60-2C65 Approved [47]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [48]
Etretinate DM2CZFA Keratosis ED56 Approved [49]
Prednisone DM2HG4X Acute asthma CA23 Approved [50]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [51]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [52]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [53]
Gefitinib DM15F0X Colon adenocarcinoma Approved [54]
Prednisone DM2HG4X Acute asthma CA23 Approved [50]
Methotrexate DM2TEOL Anterior urethra cancer Approved [55]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [56]
Lapatinib DM3BH1Y Breast cancer 2C60-2C65 Approved [57]
Quercetin DM3NC4M Obesity 5B81 Approved [58]
Fluoxetine DM3PD2C Bipolar depression Approved [59]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [60]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [61]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [62]
Gefitinib DM15F0X Colon adenocarcinoma Approved [63]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [64]
Epinephrine DM3KJBC Acute asthma CA23 Approved [65]
Quercetin DM3NC4M Obesity 5B81 Approved [66]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [67]
Fructose DM43AN2 Vomiting MD90 Approved [68]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [69]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [70]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [71]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome c (CYCS)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [72]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [73]
Gefitinib DM15F0X Colon adenocarcinoma Approved [74]
Leuprorelin acetate DM15HAT Prostate cancer 2C82.0 Approved [75]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [76]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [77]
Methotrexate DM2TEOL Anterior urethra cancer Approved [78]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [80]
Pefloxacin DM49IGF Gonococcal urethritis 1A70.0Y Approved [81]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [72]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [82]
Selenium DM25CGV N. A. N. A. Approved [83]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [84]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [85]
Deoxycholic acid DM3GYAL Subcutaneous fat disorder EF02 Approved [86]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [87]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [88]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [89]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [90]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [91]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [91]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [91]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [91]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [95]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [96]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [100]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [103]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
methyl p-hydroxybenzoate DMO58UW Discovery agent N.A. Investigative [107]
KOJIC ACID DMP84CS Discovery agent N.A. Investigative [108]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Panobinostat DM58WKG Chronic graft versus host disease Approved [109]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [110]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [109]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [112]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
Milchsaure DM462BT Pruritus EC90 Investigative [113]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [100]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [114]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [117]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [118]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [119]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
2-deoxyglucose DMIAHVU Solid tumour/cancer 2A00-2F9Z Approved [120]
Bleomycin DMNER5S Cervical cancer 2C77.0 Approved [120]
Hydroxyurea DMOQVU9 Chronic myelogenous leukaemia 2A20.0 Approved [120]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [121]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [95]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Camptothecin DM6CHNJ Solid tumour/cancer 2A00-2F9Z Phase 3 [120]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [123]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [124]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Zalcitabine DMH7MUV Human immunodeficiency virus infection 1C62 Approved [126]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [127]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [129]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [83]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [130]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [131]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [132]
Methotrexate DM2TEOL Anterior urethra cancer Approved [133]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Testosterone DM7HUNW Hot flushes GA30 Approved [134]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [135]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [136]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [137]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [138]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [139]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ethanol DMDRQZU Chronic pain MG30 Approved [140]
Menthol DMG2KW7 Back pain ME84.Z Approved [141]
Paclitaxel DMLB81S Breast carcinoma Approved [142]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [143]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [144]
Tamibarotene DM3G74J T-cell leukaemia 2A90 Phase 3 [145]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [146]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [147]
DNCB DMDTVYC Immune System disease 4A01-4B41 Phase 2 [148]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [149]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [150]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Testosterone DM7HUNW Hot flushes GA30 Approved [134]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [152]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [103]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [154]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Synaptojanin-2 (SYNJ2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Selenium DM25CGV N. A. N. A. Approved [83]
Methotrexate DM2TEOL Anterior urethra cancer Approved [78]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [155]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [156]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [152]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [157]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [158]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [159]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Glucosamine DM4ZLFD Osteoarthritis FA00-FA05 Approved [160]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [161]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [156]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [162]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [163]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [154]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [130]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [131]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [165]
Deguelin DMXT7WG Esophageal squamous cell carcinoma 2E60.1 Investigative [166]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [167]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [83]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [92]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
Torcetrapib DMDHYM7 Hyperlipidaemia 5C80 Discontinued in Phase 2 [168]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cochlin (COCH)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [169]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [91]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [91]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [91]
Adefovir Dipivoxil DMMAWY1 Hepatitis B virus infection 1E51.0 Approved [91]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Epsilon-sarcoglycan (SGCE)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Folic Acid DMEMBJC Colorectal carcinoma Approved [170]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [171]
Methotrexate DM2TEOL Anterior urethra cancer Approved [167]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [167]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [167]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [172]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [173]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [174]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [175]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [176]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Enzalutamide DMGL19D Prostate cancer 2C82.0 Approved [177]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [178]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Nardilysin (NRDC)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [173]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
DNCB DMDTVYC Immune System disease 4A01-4B41 Phase 2 [148]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [179]
3R14S-OCHRATOXIN A DM2KEW6 Discovery agent N.A. Investigative [179]
Milchsaure DM462BT Pruritus EC90 Investigative [113]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [180]
Tributylstannanyl DMHN7CB Discovery agent N.A. Investigative [179]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [114]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [181]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [114]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [152]
Testosterone enanthate DMB6871 N. A. N. A. Approved [182]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [183]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [165]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [184]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [185]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [95]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [105]
OTX-015 DMI8RG1 Acute myeloid leukaemia 2A60 Phase 1/2 [186]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [187]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [188]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [189]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [184]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Testosterone enanthate DMB6871 N. A. N. A. Approved [182]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [190]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [173]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [191]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [192]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [121]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [193]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [194]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [195]
DNCB DMDTVYC Immune System disease 4A01-4B41 Phase 2 [148]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Selenoprotein F (SELENOF)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [196]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Selenium DM25CGV N. A. N. A. Approved [197]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [198]
Milchsaure DM462BT Pruritus EC90 Investigative [113]
AHPN DM8G6O4 Discovery agent N.A. Investigative [199]
chloropicrin DMSGBQA Discovery agent N.A. Investigative [200]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Catenin delta-1 (CTNND1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [62]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [201]
Methotrexate DM2TEOL Anterior urethra cancer Approved [133]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [97]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [202]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Panobinostat DM58WKG Chronic graft versus host disease Approved [109]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Testosterone enanthate DMB6871 N. A. N. A. Approved [182]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [203]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [204]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [205]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [188]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [207]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [208]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [131]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
cycloheximide DMGDA3C Discovery agent N.A. Investigative [209]
⏷ Show the Full List of 8 Drug(s)
Drug(s) Affected By ICOS ligand (ICOSLG)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [78]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [210]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [211]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [121]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [95]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [194]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [212]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [189]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [213]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Motexafin gadolinium DMEJKRF Brain cancer 2A00 Approved [189]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [127]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Reticulon-2 (RTN2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [184]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [95]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [194]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [187]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Panobinostat DM58WKG Chronic graft versus host disease Approved [109]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [121]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [97]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [143]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [173]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
APR-246 DMNFADH Ovarian cancer 2C73 Phase 2 [214]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [130]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
Glyphosate DM0AFY7 Malaria 1F40-1F45 Investigative [215]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Affected By Tetraspanin-9 (TSPAN9)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [204]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [194]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [62]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [79]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [216]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [203]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [203]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [138]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [169]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [217]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [218]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Vinblastine DM5TVS3 Advanced cancer 2A00-2F9Z Approved [167]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [133]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [219]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [203]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [203]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [100]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [117]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [177]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [220]
Methotrexate DM2TEOL Anterior urethra cancer Approved [221]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [222]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [216]
Bortezomib DMNO38U Leukemia Approved [136]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Myoglobin (MB)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [223]
Succinylcholine DM2ET1M Plasma cell myeloma 2A83.1 Approved [224]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [225]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [226]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [117]
Zalcitabine DMH7MUV Human immunodeficiency virus infection 1C62 Approved [227]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [109]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [150]
Selenium DM25CGV N. A. N. A. Approved [83]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [228]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [222]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [229]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [230]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [210]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Paclitaxel DMLB81S Breast carcinoma Approved [231]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [232]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [97]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [233]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Benzatropine DMF7EXL Parkinsonian disorder Approved [234]
Sulfasalazine DMICA9H Irritable bowel syndrome DD91.0 Approved [235]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [235]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [236]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [203]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [237]
Selenium DM25CGV N. A. N. A. Approved [83]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [238]
Quercetin DM3NC4M Obesity 5B81 Approved [239]
Glimepiride DM5FSJA Diabetic complication 5A2Y Approved [240]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [241]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [242]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Cantharidin DMBP5N3 Molluscum contagiosum infection 1E76 Approved [243]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [244]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [72]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [245]
Gefitinib DM15F0X Colon adenocarcinoma Approved [246]
Selenium DM25CGV N. A. N. A. Approved [83]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [247]
Quercetin DM3NC4M Obesity 5B81 Approved [248]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [249]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Flupentixol DM0DJ9O Schizophrenia 6A20 Approved [250]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [251]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [252]
Lamotrigine DM8SXYG Bipolar disorder 6A60 Approved [253]
Cepharanthine DM9Y5JB N. A. N. A. Approved [254]
Itraconazole DMCR1MV Aspergillosis 1F20 Approved [255]
Clozapine DMFC71L Schizophrenia 6A20 Approved [256]
Midostaurin DMI6E0R Acute myeloid leukaemia 2A60 Approved [257]
Trifluoperazine DMKBYWI Anxiety Approved [258]
Olanzapine DMPFN6Y Bipolar depression Approved [256]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Imatinib DM7RJXL Acute lymphoblastic leukaemia 2A85 Approved [259]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [260]
Clotrimazole DMMFCIH Cutaneous candidiasis 1F23.14 Approved [259]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [261]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [262]
Bardoxolone methyl DMODA2X Mixed connective tissue disease 4A43.3 Phase 3 [263]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cabozantinib DMIYDT4 Medullary thyroid gland carcinoma Approved [264]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [265]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [266]
Lumiracoxib DM1S4AG Chronic renal failure GB61.Z Approved [266]
Clavulanate DM2FGRT Bacteremia 1A73 Approved [266]
Methotrexate DM2TEOL Anterior urethra cancer Approved [267]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [266]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [268]
Methylprednisolone DM4BDON Acute adrenal insufficiency Approved [267]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Gamma-enolase (ENO2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [269]
Estrone DM5T6US Acne vulgaris ED80 Approved [270]
Aluminium DM6ECN9 Hyperhidrosis EE00 Approved [271]
LY2835219 DM93VBZ Breast cancer 2C60-2C65 Approved [272]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [91]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [91]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [110]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Matrilysin (MMP7)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [221]
Quercetin DM3NC4M Obesity 5B81 Approved [273]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [274]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [192]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [275]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Propofol DMB4OLE Anaesthesia 9A78.6 Approved [276]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [277]
Clozapine DMFC71L Schizophrenia 6A20 Approved [278]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [279]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Poly polymerase 1 (PARP1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [280]
Gefitinib DM15F0X Colon adenocarcinoma Approved [74]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [281]
Nitric Oxide DM1RBYG Hypertension BA00-BA04 Approved [282]
Citalopram DM2G9AE Acute coronary syndrome BA41 Approved [283]
Ciprofloxacin XR DM2NLS9 Acute gonococcal cervicitis Approved [51]
Imipramine DM2NUH3 Depression 6A70-6A7Z Approved [283]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [284]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [285]
Methotrexate DM2TEOL Anterior urethra cancer Approved [286]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Quercetin DM3NC4M Obesity 5B81 Approved [287]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [138]
Vismodegib DM5IXKQ Basal cell carcinoma 2C32 Approved [288]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [289]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [156]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [157]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [290]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [88]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [275]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [185]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [291]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [237]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [220]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [292]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [175]
Etretinate DM2CZFA Keratosis ED56 Approved [293]
Quercetin DM3NC4M Obesity 5B81 Approved [294]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [295]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [233]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [249]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [296]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein 4.1 (EPB41)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [297]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [187]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Plastin-3 (PLS3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Testosterone DM7HUNW Hot flushes GA30 Approved [134]
Haloperidol DM96SE0 Delirium Approved [234]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Clozapine DMFC71L Schizophrenia 6A20 Approved [234]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [298]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Malathion DMXZ84M Pediculus capitis infestation 1G00.0 Approved [299]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [173]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [300]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [301]
Testosterone DM7HUNW Hot flushes GA30 Approved [302]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [121]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [117]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [227]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By CD59 glycoprotein (CD59)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [72]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [303]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [304]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [184]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [305]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Ethanol DMDRQZU Chronic pain MG30 Approved [306]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [127]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [307]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [305]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [127]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [72]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Methotrexate DM2TEOL Anterior urethra cancer Approved [221]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [156]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [308]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Clozapine DMFC71L Schizophrenia 6A20 Approved [309]
Pentamidine DMHZJCG African trypanosomiasis 1F51 Approved [310]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
DTI-015 DMXZRW0 Brain cancer 2A00 Approved [311]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [312]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [313]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Disulfiram DMCL2OK Alcohol dependence 6C40.2 Approved [314]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [315]
Phenytoin DMNOKBV Epilepsy 8A60-8A68 Approved [316]
Dacarbazine DMNPZL4 Adenocarcinoma 2D40 Approved [317]
Topotecan DMP6G8T Central nervous system neoplasm Approved [318]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Clozapine DMFC71L Schizophrenia 6A20 Approved [319]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Folic Acid DMEMBJC Colorectal carcinoma Approved [170]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [320]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [321]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [117]
Nortriptyline DM4KDYJ Depression 6A70-6A7Z Approved [322]
Sibutramine DMFJTDI Obesity 5B81 Approved [323]
Almogran DM7I64Z Migraine 8A80 Approved [324]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [325]
Chloroquine DMSI5CB Malaria 1F40-1F45 Approved [326]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [121]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [327]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [96]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Calpastatin (CAST)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Testosterone DM7HUNW Hot flushes GA30 Approved [134]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Dihydroartemisinin DMBXVMZ Malaria 1F40-1F45 Approved [328]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [185]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [193]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Neurofibromin (NF1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [189]
Panobinostat DM58WKG Chronic graft versus host disease Approved [109]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [156]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [329]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Motexafin gadolinium DMEJKRF Brain cancer 2A00 Approved [189]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tolbutamide DM02AWV Advanced cancer 2A00-2F9Z Approved [330]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [280]
Methotrexate DM2TEOL Anterior urethra cancer Approved [331]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [332]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Cyclophosphamide DM4O2Z7 Advanced cancer 2A00-2F9Z Approved [330]
Ethacrynic acid DM60QMR Edema MG29 Approved [333]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [334]
Trovafloxacin DM6AN32 Acute gonococcal cervicitis Approved [335]
Clonidine DM6RZ9Q Attention deficit hyperactivity disorder 6A05.Z Approved [330]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Methotrexate DM2TEOL Anterior urethra cancer Approved [133]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [336]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [210]
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [184]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Clozapine DMFC71L Schizophrenia 6A20 Approved [234]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [88]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [189]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Testosterone enanthate DMB6871 N. A. N. A. Approved [182]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Motexafin gadolinium DMEJKRF Brain cancer 2A00 Approved [189]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [136]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [232]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [127]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [138]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [143]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Josamycin DMKJ8LB Bacterial infection 1A00-1C4Z Approved [337]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [338]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [339]
Panobinostat DM58WKG Chronic graft versus host disease Approved [109]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [156]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Indomethacin DMSC4A7 Bursitis Approved [340]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [109]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [117]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [341]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [342]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [343]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [344]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [345]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [346]
Secobarbital DM14RF5 Epilepsy 8A60-8A68 Approved [347]
Gefitinib DM15F0X Colon adenocarcinoma Approved [348]
Fexofenadine DM17ONX Allergic rhinitis CA08.0 Approved [349]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [350]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ethanol DMDRQZU Chronic pain MG30 Approved [351]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [342]
Carvedilol DMHTEAO Chronic heart failure BD1Z Approved [352]
Paclitaxel DMLB81S Breast carcinoma Approved [353]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [354]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [341]
Urokinase DM0GOUD Myocardial infarction BA41-BA43 Approved [227]
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [72]
Sertraline DM0FB1J Coronary heart disease BA80.Z Approved [344]
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [345]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Myeloid zinc finger 1 (MZF1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [110]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [194]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [355]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [130]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [228]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Clozapine DMFC71L Schizophrenia 6A20 Approved [234]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [356]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [357]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Clorgyline DMCEUJD Parkinson disease 8A00.0 Approved [358]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [97]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [359]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [360]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [175]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [216]
Epanova DMHEAGL Hypertriglyceridemia 5C80.1 Approved [361]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [362]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [363]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [181]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [95]
Azelaic Acid DMHVL0J Acne vulgaris ED80 Approved [364]
Isoproterenol DMK7MEY Atrioventricular block Approved [364]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [177]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Matrin-3 (MATR3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [292]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [138]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [216]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [365]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [292]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [109]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [366]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [221]
Dactinomycin DM2YGNW Adult kidney Wilms tumor Approved [367]
Quercetin DM3NC4M Obesity 5B81 Approved [300]
Testosterone DM7HUNW Hot flushes GA30 Approved [134]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Menthol DMG2KW7 Back pain ME84.Z Approved [141]
Sorafenib DMS8IFC Adenocarcinoma 2D40 Approved [368]
Indomethacin DMSC4A7 Bursitis Approved [369]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [370]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [72]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [291]
Bortezomib DMNO38U Leukemia Approved [136]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [193]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [130]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [175]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [156]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Clozapine DMFC71L Schizophrenia 6A20 Approved [234]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [130]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [88]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Clozapine DMFC71L Schizophrenia 6A20 Approved [234]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [371]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [194]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [90]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Bortezomib DMNO38U Leukemia Approved [136]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [372]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [373]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [216]
Deguelin DMXT7WG Esophageal squamous cell carcinoma 2E60.1 Investigative [166]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [114]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [83]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [130]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By DNA ligase 4 (LIG4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [374]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Clorgyline DMCEUJD Parkinson disease 8A00.0 Approved [358]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [185]
Bortezomib DMNO38U Leukemia Approved [136]
Arsenic DMTL2Y1 N. A. N. A. Approved [375]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Nicotine DMWX5CO Lung cancer 2C25.0 Approved [376]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Fenfluramine DM0762O Dravet syndrome 8A61.11 Phase 3 [377]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Biotin--protein ligase (HLCS)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [114]
Quercetin DM3NC4M Obesity 5B81 Approved [378]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [169]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [114]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [173]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [379]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [97]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [380]
Selenium DM25CGV N. A. N. A. Approved [83]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [189]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [329]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Motexafin gadolinium DMEJKRF Brain cancer 2A00 Approved [189]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [150]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [152]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [190]
Menthol DMG2KW7 Back pain ME84.Z Approved [141]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [381]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [382]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By IST1 homolog (IST1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [383]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [109]
methyl p-hydroxybenzoate DMO58UW Discovery agent N.A. Investigative [107]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Estrone DM5T6US Acne vulgaris ED80 Approved [270]
Ethacrynic acid DM60QMR Edema MG29 Approved [384]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [110]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Furosemide DMMQ8ZG Congestive heart failure BD10 Approved [384]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [270]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Bax inhibitor 1 (TMBIM6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [88]
Testosterone DM7HUNW Hot flushes GA30 Approved [134]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [110]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Tamibarotene DM3G74J T-cell leukaemia 2A90 Phase 3 [88]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [216]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [78]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Benzatropine DMF7EXL Parkinsonian disorder Approved [234]
Clozapine DMFC71L Schizophrenia 6A20 Approved [234]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [385]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [386]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [373]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [387]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [280]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [184]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [95]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [194]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [109]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [291]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [388]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [389]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [83]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [92]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [390]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [391]
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [62]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [392]
Methotrexate DM2TEOL Anterior urethra cancer Approved [78]
Cladribine DM3JDRP Hairy cell leukaemia 2A82.2 Approved [393]
Quercetin DM3NC4M Obesity 5B81 Approved [394]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [395]
Thalidomide DM70BU5 Adult T-cell leukemia/lymphoma Approved [396]
Testosterone DM7HUNW Hot flushes GA30 Approved [134]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [397]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [374]
Lovastatin DM9OZWQ Arteriosclerosis BD40 Approved [398]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [399]
Pioglitazone DMKJ485 Amyotrophic lateral sclerosis 8B60.0 Approved [400]
Bortezomib DMNO38U Leukemia Approved [136]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [401]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [211]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [100]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [332]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [402]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [402]
Panobinostat DM58WKG Chronic graft versus host disease Approved [109]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [403]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [374]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Lovastatin DM9OZWQ Arteriosclerosis BD40 Approved [404]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Atorvastatin DMF28YC Acute coronary syndrome BA41 Approved [405]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [406]
Ursodeoxycholic acid DMCUT21 Cholelithiasis DC11 Approved [407]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [218]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [383]
Milchsaure DM462BT Pruritus EC90 Investigative [113]
Rapamycin Immunosuppressant Drug DM678IB Discovery agent N.A. Investigative [408]
chloropicrin DMSGBQA Discovery agent N.A. Investigative [409]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [175]
Quercetin DM3NC4M Obesity 5B81 Approved [410]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [411]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [412]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [413]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Menthol DMG2KW7 Back pain ME84.Z Approved [141]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Panobinostat DM58WKG Chronic graft versus host disease Approved [109]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [334]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [211]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [138]
Testosterone DM7HUNW Hot flushes GA30 Approved [134]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [157]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [414]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Arsenic DMTL2Y1 N. A. N. A. Approved [415]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [416]
Methotrexate DM2TEOL Anterior urethra cancer Approved [417]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [332]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Riboflavin DM8YMWE Acne vulgaris ED80 Approved [418]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [184]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [169]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [210]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [157]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [372]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Dystonin (DST)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [62]
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [88]
Panobinostat DM58WKG Chronic graft versus host disease Approved [109]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [210]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Clorgyline DMCEUJD Parkinson disease 8A00.0 Approved [358]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Folic Acid DMEMBJC Colorectal carcinoma Approved [170]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [133]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [103]
Bortezomib DMNO38U Leukemia Approved [136]
Azacitidine DMTA5OE Acute myelogenous leukaemia 2A41 Approved [298]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [218]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Dynamin-1 (DNM1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [169]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [275]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [110]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [105]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [187]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Bortezomib DMNO38U Leukemia Approved [136]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [96]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [183]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [173]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [419]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [420]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [421]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [152]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Benzatropine DMF7EXL Parkinsonian disorder Approved [234]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [211]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [365]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Quercetin DM3NC4M Obesity 5B81 Approved [294]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [173]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Clozapine DMFC71L Schizophrenia 6A20 Approved [234]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [121]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [97]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [175]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Testosterone enanthate DMB6871 N. A. N. A. Approved [182]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [173]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [103]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
Topotecan DMP6G8T Central nervous system neoplasm Approved [167]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Secernin-3 (SCRN3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Testosterone DM7HUNW Hot flushes GA30 Approved [134]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [187]
Geldanamycin DMS7TC5 Kidney cancer 2C90.0 Discontinued in Phase 2 [422]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [216]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [109]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Testosterone enanthate DMB6871 N. A. N. A. Approved [182]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [204]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [423]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [96]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [205]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Bortezomib DMNO38U Leukemia Approved [136]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [194]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [424]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
COUMESTROL DM40TBU Discovery agent N.A. Investigative [96]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [133]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [177]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [425]
Paromomycin DM1AGXN Amoebiasis 1A36 Approved [426]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [427]
Etretinate DM2CZFA Keratosis ED56 Approved [49]
Quercetin DM3NC4M Obesity 5B81 Approved [428]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Remdesivir DMBFZ6L Coronavirus Disease 2019 (COVID-19) 1D6Y Approved [429]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [189]
Rifampicin DM5DSFZ Non-insulin dependent diabetes 5A11 Approved [363]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [430]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [431]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [88]
Acocantherin DM7JT24 Atrial fibrillation BC81.3 Approved [412]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Testosterone enanthate DMB6871 N. A. N. A. Approved [182]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [216]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Ethanol DMDRQZU Chronic pain MG30 Approved [140]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Paclitaxel DMLB81S Breast carcinoma Approved [432]
Aprepitant DM053KT Depression 6A70-6A7Z Approved [433]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [434]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [420]
Crizotinib DM4F29C Non-small-cell lung cancer 2C25.Y Approved [265]
Chlorpromazine DMBGZI3 Acute intermittent hepatic porphyria 5C58.11 Approved [435]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [436]
Trovafloxacin DM6AN32 Acute gonococcal cervicitis Approved [335]
Etodolac DM6WJO9 Osteoarthritis FA00-FA05 Approved [437]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [438]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [221]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [439]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Amphotericin B DMTAJQE Acne vulgaris ED80 Approved [440]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [174]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [83]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Methotrexate DM2TEOL Anterior urethra cancer Approved [221]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [155]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [441]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Menthol DMG2KW7 Back pain ME84.Z Approved [141]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [325]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [216]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [442]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [173]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Colchicine DM2POTE Acute gout flare FA25.0 Approved [443]
Panobinostat DM58WKG Chronic graft versus host disease Approved [109]
Vinblastine DM5TVS3 Advanced cancer 2A00-2F9Z Approved [443]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ethanol DMDRQZU Chronic pain MG30 Approved [444]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [370]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
Phenylephrine DMZHUO5 Allergic rhinitis CA08.0 Approved [445]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [109]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [118]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [292]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Selenium DM25CGV N. A. N. A. Approved [83]
Methotrexate DM2TEOL Anterior urethra cancer Approved [133]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [446]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [446]
Testosterone enanthate DMB6871 N. A. N. A. Approved [182]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [185]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Folic Acid DMEMBJC Colorectal carcinoma Approved [170]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [447]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Berberine DMC5Q8X N. A. N. A. Phase 4 [448]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [130]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [131]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [449]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [401]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [103]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [450]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [95]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [173]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Methotrexate DM2TEOL Anterior urethra cancer Approved [78]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Testosterone enanthate DMB6871 N. A. N. A. Approved [182]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [177]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [211]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [194]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [105]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [118]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
THAPSIGARGIN DMDMQIE N. A. N. A. Preclinical [451]
Sulforaphane DMQY3L0 Skin disease EA00-EM0Z Investigative [452]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [133]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [124]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [143]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [453]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
DNCB DMDTVYC Immune System disease 4A01-4B41 Phase 2 [148]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [134]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
Deguelin DMXT7WG Esophageal squamous cell carcinoma 2E60.1 Investigative [166]
⏷ Show the Full List of 7 Drug(s)
Drug(s) Affected By Drebrin (DBN1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [169]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [192]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [110]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Ethanol DMDRQZU Chronic pain MG30 Approved [454]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [103]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [455]
Methotrexate DM2TEOL Anterior urethra cancer Approved [417]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [332]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [138]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [334]
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [184]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [79]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [114]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [386]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [456]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [233]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [124]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [79]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [173]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Clozapine DMFC71L Schizophrenia 6A20 Approved [234]
Fenofibrate DMFKXDY Coronary atherosclerosis Approved [457]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [456]
Acetic Acid, Glacial DM4SJ5Y infection in the ear canal AA0Y Approved [189]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [114]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Ethanol DMDRQZU Chronic pain MG30 Approved [458]
Motexafin gadolinium DMEJKRF Brain cancer 2A00 Approved [189]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein moonraker (KIAA0753)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [366]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [459]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Drug(s) Affected By NADH dehydrogenase (NDUFAF6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [105]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [146]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [460]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [442]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Milchsaure DM462BT Pruritus EC90 Investigative [113]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Testosterone DM7HUNW Hot flushes GA30 Approved [134]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Arsenic DMTL2Y1 N. A. N. A. Approved [461]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Sodium phenylbutyrate DMXLBCQ Spinal muscular atrophy 8B61 Approved [462]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
⏷ Show the Full List of 8 Drug(s)
Drug(s) Affected By Neuritin-like protein (NRN1L)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [203]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [203]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [112]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
⏷ Show the Full List of 6 Drug(s)
Drug(s) Affected By Protein Hikeshi (HIKESHI)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [138]
Testosterone DM7HUNW Hot flushes GA30 Approved [134]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [103]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [204]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [424]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [463]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
⏷ Show the Full List of 7 Drug(s)
Drug(s) Affected By Puratrophin-1 (PLEKHG4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [464]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [291]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [203]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [121]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [105]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Histone H2B type 2-F (H2BC18)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [121]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [299]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [465]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [460]
⏷ Show the Full List of 6 Drug(s)
Drug(s) Affected By Protein odr-4 homolog (ODR4)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [169]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [79]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Epigallocatechin gallate DMCGWBJ Hepatic fibrosis DB93.0 Phase 3 [466]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [338]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [143]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [183]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [131]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [175]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [184]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [146]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [79]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [134]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [136]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [194]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [299]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [338]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Kynurenine formamidase (AFMID)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [95]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [187]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [467]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [62]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [274]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [156]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [152]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [110]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [321]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [117]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [175]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Melphalan DMOLNHF Hematologic disease 3C0Z Approved [178]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [100]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [90]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [124]
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [184]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [468]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [177]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [187]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [184]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [468]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [95]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [469]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Phostensin (PPP1R18)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [62]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [110]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [470]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [203]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [203]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [114]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [210]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [204]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [97]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [471]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Cytochrome P450 20A1 (CYP20A1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [103]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [203]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [203]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [157]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [472]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [100]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [105]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [424]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [390]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [156]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [463]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [387]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [216]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [97]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [143]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [83]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Ceramide synthase 6 (CERS6)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [473]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [204]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [194]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [205]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [92]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [474]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [173]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [131]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [475]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [180]
Octanal DMTN0OK N. A. N. A. Investigative [476]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
PMID28870136-Compound-48 DMPIM9L N. A. N. A. Patented [90]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [180]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [191]
⏷ Show the Full List of 7 Drug(s)
Drug(s) Affected By LanC-like protein 3 (LANCL3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [463]
Milchsaure DM462BT Pruritus EC90 Investigative [113]
Sulforaphane DMQY3L0 Skin disease EA00-EM0Z Investigative [452]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Malathion DMXZ84M Pediculus capitis infestation 1G00.0 Approved [299]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [477]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [134]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [203]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [130]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [175]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [456]
Panobinostat DM58WKG Chronic graft versus host disease Approved [109]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [110]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [97]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [138]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [478]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [372]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [173]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
THAPSIGARGIN DMDMQIE N. A. N. A. Preclinical [451]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein MON2 homolog (MON2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Clorgyline DMCEUJD Parkinson disease 8A00.0 Approved [358]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Folic Acid DMEMBJC Colorectal carcinoma Approved [170]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [325]
Arsenic DMTL2Y1 N. A. N. A. Approved [461]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [183]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [83]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [130]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [109]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [83]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [479]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [130]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [131]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [156]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [338]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Panobinostat DM58WKG Chronic graft versus host disease Approved [109]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [372]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [194]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
Sodium chloride DMM3950 Skin burns ME65.0 Approved [480]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [109]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Sodium phenylbutyrate DMXLBCQ Spinal muscular atrophy 8B61 Approved [462]
Isoflavone DM7U58J N. A. N. A. Phase 4 [481]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
Okadaic acid DM47CO1 Discovery agent N.A. Investigative [482]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [97]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Milchsaure DM462BT Pruritus EC90 Investigative [113]
⏷ Show the Full List of 6 Drug(s)
Drug(s) Affected By Nostrin (NOSTRIN)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Testosterone DM7HUNW Hot flushes GA30 Approved [134]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [211]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [464]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [97]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [105]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [118]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Neuron navigator 3 (NAV3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [62]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [138]
Panobinostat DM58WKG Chronic graft versus host disease Approved [109]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [181]
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [184]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [190]
Folic Acid DMEMBJC Colorectal carcinoma Approved [170]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [157]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [483]
Testosterone DM7HUNW Hot flushes GA30 Approved [134]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [463]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [484]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [216]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [362]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Rigosertib DMOSTXF Myelodysplastic syndrome 2A37 Phase 3 [485]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [83]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [130]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [184]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [110]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [121]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [372]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [173]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [117]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [109]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein AMN1 homolog (AMN1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [468]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [486]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [487]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
Milchsaure DM462BT Pruritus EC90 Investigative [113]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [455]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [488]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [127]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [127]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [187]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [184]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [110]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Abl interactor 1 (ABI1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [173]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Bortezomib DMNO38U Leukemia Approved [136]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [100]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [489]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [169]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [422]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Folic Acid DMEMBJC Colorectal carcinoma Approved [170]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [362]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [203]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [95]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [490]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [491]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [492]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [100]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [143]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [173]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [105]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [149]
Lithium chloride DMHYLQ2 Discovery agent N.A. Investigative [493]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [175]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [109]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [109]
Hexadecanoic acid DMWUXDZ Discovery agent N.A. Investigative [494]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [468]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [173]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [131]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [390]
⏷ Show the Full List of 7 Drug(s)
Drug(s) Affected By PACRG-like protein (PACRGL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ethinyl Estradiol DMODJ40 Acne vulgaris ED80 Approved [232]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Mitoxantrone DMM39BF Acute myelogenous leukaemia 2A41 Approved [495]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [149]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [157]
Milchsaure DM462BT Pruritus EC90 Investigative [113]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [157]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
3R14S-OCHRATOXIN A DM2KEW6 Discovery agent N.A. Investigative [496]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [203]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [203]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [198]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [422]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [143]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [492]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [112]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [121]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [117]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [105]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [112]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [216]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [191]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein FAM13C (FAM13C)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Panobinostat DM58WKG Chronic graft versus host disease Approved [109]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [216]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [95]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [109]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [117]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [177]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [210]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [497]
Tubocurarine DMBZIVP Anaesthesia 9A78.6 Approved [498]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ethanol DMDRQZU Chronic pain MG30 Approved [499]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [121]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [500]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [216]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [218]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [195]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [167]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [218]
DNCB DMDTVYC Immune System disease 4A01-4B41 Phase 2 [148]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [470]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [95]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [187]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [62]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [175]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [121]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [95]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [463]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
PMID28870136-Compound-48 DMPIM9L N. A. N. A. Patented [90]
COUMESTROL DM40TBU Discovery agent N.A. Investigative [96]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Clorgyline DMCEUJD Parkinson disease 8A00.0 Approved [358]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Clozapine DMFC71L Schizophrenia 6A20 Approved [309]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [95]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [100]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [112]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
Sulforaphane DMQY3L0 Skin disease EA00-EM0Z Investigative [452]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [133]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [138]
Panobinostat DM58WKG Chronic graft versus host disease Approved [109]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Testosterone enanthate DMB6871 N. A. N. A. Approved [182]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [501]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [211]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [157]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Panobinostat DM58WKG Chronic graft versus host disease Approved [109]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [453]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [109]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [146]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
RESORCINOL DMM37C0 Discovery agent N.A. Investigative [470]
⏷ Show the Full List of 7 Drug(s)
Drug(s) Affected By Cohesin subunit SA-1 (STAG1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [110]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [203]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [502]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [484]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [105]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [187]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [191]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [138]
Panobinostat DM58WKG Chronic graft versus host disease Approved [109]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Clorgyline DMCEUJD Parkinson disease 8A00.0 Approved [358]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Paclitaxel DMLB81S Breast carcinoma Approved [503]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [504]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [62]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [505]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [97]
Arsenic DMTL2Y1 N. A. N. A. Approved [506]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [96]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [280]
Selenium DM25CGV N. A. N. A. Approved [83]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [210]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [173]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [216]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [464]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [507]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [365]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Methotrexate DM2TEOL Anterior urethra cancer Approved [133]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [152]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Clodronate DM9Y6X7 Hypercalcaemia 5B91.0 Approved [91]
Cidofovir DMA13GD Cytomegalovirus infection 1D82 Approved [91]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [91]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ifosfamide DMCT3I8 Adult central nervous system germ cell tumor Approved [91]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [228]
Ibuprofen DM8VCBE Dysmenorrhea GA34.3 Approved [508]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [97]
DNCB DMDTVYC Immune System disease 4A01-4B41 Phase 2 [148]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [130]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [165]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [464]
Bortezomib DMNO38U Leukemia Approved [509]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
⏷ Show the Full List of 8 Drug(s)
Drug(s) Affected By Lipoma-preferred partner (LPP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [62]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [332]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [510]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [510]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Piroxicam DMTK234 Osteoarthritis FA00-FA05 Approved [193]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [195]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [511]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [321]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [188]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [455]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [156]
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [184]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [79]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [464]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [488]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [470]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [169]
Liothyronine DM6IR3P Congenital hypothyroidism Approved [512]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [291]
Arsenic DMTL2Y1 N. A. N. A. Approved [513]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [143]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [130]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [424]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [475]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [194]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Drug(s) Affected By Endonuclease 8-like 1 (NEIL1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [514]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [109]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
Sulforaphane DMQY3L0 Skin disease EA00-EM0Z Investigative [452]
⏷ Show the Full List of 8 Drug(s)
Drug(s) Affected By Serine dehydratase-like (SDSL)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
PDX-101 DM6OC53 Plasma cell myeloma 2A83.1 Phase 2 [109]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [92]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
THAPSIGARGIN DMDMQIE N. A. N. A. Preclinical [515]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [460]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By RUS family member 1 (RUSF1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [78]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [181]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [97]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [90]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Haloperidol DM96SE0 Delirium Approved [234]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Folic Acid DMEMBJC Colorectal carcinoma Approved [170]
Benzatropine DMF7EXL Parkinsonian disorder Approved [234]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [90]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [203]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [130]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [175]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [97]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [173]
Curcumin DMQPH29 Solid tumour/cancer 2A00-2F9Z Phase 3 [516]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [196]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [216]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [143]
Torcetrapib DMDHYM7 Hyperlipidaemia 5C80 Discontinued in Phase 2 [168]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [198]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [216]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [191]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [417]
Panobinostat DM58WKG Chronic graft versus host disease Approved [109]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [152]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [103]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [442]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [109]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [463]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [152]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [517]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [195]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [119]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [165]
KOJIC ACID DMP84CS Discovery agent N.A. Investigative [108]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [464]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [121]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [112]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [468]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [121]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
Milchsaure DM462BT Pruritus EC90 Investigative [113]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [173]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [216]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [211]
Diclofenac DMPIHLS Chronic renal failure GB61.Z Approved [127]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [388]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [174]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Bortezomib DMNO38U Leukemia Approved [136]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [463]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [131]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [184]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [110]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [109]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Permethrin DMZ0Q1G Pediculus capitis infestation 1G00.0 Approved [299]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [177]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [173]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Folic Acid DMEMBJC Colorectal carcinoma Approved [518]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [329]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Benzatropine DMF7EXL Parkinsonian disorder Approved [234]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [83]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
Sulforaphane DMQY3L0 Skin disease EA00-EM0Z Investigative [452]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [156]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [95]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [194]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
GSK2110183 DMZHB37 leukaemia 2A60-2B33 Phase 2 [519]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [520]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [90]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [336]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [483]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [152]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [173]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [216]
Hydrocortisone DMGEMB7 Acne vulgaris ED80 Approved [521]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [136]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Homeobox protein Meis3 (MEIS3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [464]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [117]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
Drug(s) Affected By Ataxin-2 (ATXN2)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [62]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [121]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [184]
LY2835219 DM93VBZ Breast cancer 2C60-2C65 Approved [272]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [216]
Palbociclib DMD7L94 Breast cancer 2C60-2C65 Approved [522]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Azathioprine DMMZSXQ Lupus nephritis 4A40.0Y Approved [470]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Clozapine DMFC71L Schizophrenia 6A20 Approved [234]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [218]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [523]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [173]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [524]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [90]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Testosterone DM7HUNW Hot flushes GA30 Approved [134]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [216]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [203]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [203]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Protein FAM110A (FAM110A)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [275]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [173]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [424]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [105]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [95]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [105]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [332]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [203]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [525]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [525]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [525]
Pyrrolidine dithiocarbamate DM5ZAS6 Discovery agent N.A. Investigative [526]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [156]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [527]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Heroin diacetylmorphine DMDBWHY Neurological disorder 6B60 Approved [528]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [528]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [372]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [529]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [95]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [424]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [417]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [216]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [121]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [96]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [175]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [114]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [95]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [184]
Folic Acid DMEMBJC Colorectal carcinoma Approved [530]
Menthol DMG2KW7 Back pain ME84.Z Approved [141]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [136]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [121]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [143]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [531]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Kanadaptin (SLC4A1AP)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [131]
Hexadecanoic acid DMWUXDZ Discovery agent N.A. Investigative [494]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [234]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
PP-242 DM2348V Discovery agent N.A. Investigative [532]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [121]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [95]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [105]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [463]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [216]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Affected By Hyccin (HYCC1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [62]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [152]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [185]
Folic Acid DMEMBJC Colorectal carcinoma Approved [533]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [534]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
Geldanamycin DMS7TC5 Kidney cancer 2C90.0 Discontinued in Phase 2 [422]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Colchicine DM2POTE Acute gout flare FA25.0 Approved [52]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [156]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Mitomycin DMH0ZJE Breast cancer 2C60-2C65 Approved [52]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Etoposide DMNH3PG Acute myelogenous leukaemia 2A41 Approved [52]
Hydroxyurea DMOQVU9 Chronic myelogenous leukaemia 2A20.0 Approved [52]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [110]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [203]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [203]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [154]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Genistein DM0JETC Menopause symptom GA30.0 Phase 2/3 [535]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [536]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [152]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Sanguinarine DMDINFS Dental plaque DA08.4 Approved [536]
Menthol DMG2KW7 Back pain ME84.Z Approved [141]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Resveratrol DM3RWXL Giant cell arteritis 4A44.2 Phase 3 [537]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [112]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Promethazine DM6I5GR Hyperemesis gravidarum Approved [538]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [539]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [83]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [112]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [338]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [180]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Affected By NIF3-like protein 1 (NIF3L1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [184]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [97]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [292]
Simvastatin DM30SGU Arteriosclerosis BD40 Approved [540]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [334]
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [184]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Palbociclib DMD7L94 Breast cancer 2C60-2C65 Approved [522]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Menadione DMSJDTY Vitamin K deficiency 5B59 Approved [97]
TAK-243 DM4GKV2 Solid tumour/cancer 2A00-2F9Z Phase 1 [130]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [464]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [194]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [173]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Affected By Protein ARV1 (ARV1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
Milchsaure DM462BT Pruritus EC90 Investigative [113]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [216]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Affected By STING ER exit protein (STEEP1)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [105]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [90]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [173]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [173]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [83]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [184]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [194]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [100]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
Milchsaure DM462BT Pruritus EC90 Investigative [113]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [110]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [194]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [187]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [165]
⏷ Show the Full List of 7 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [175]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [156]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [541]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [194]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [157]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Dasatinib DMJV2EK Blast phase chronic myelogenous leukemia, BCR-ABL1 positive Approved [488]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [477]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [109]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [185]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [121]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [218]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [177]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [138]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [291]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [121]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Dihydrotestosterone DM3S8XC Prostate hyperplasia GA90 Phase 4 [177]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [112]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [158]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Nefazodone DM4ZS8M Major depressive disorder 6A70.3 Approved [542]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [181]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [185]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [121]
Sorafenib DMS8IFC Adenocarcinoma 2D40 Approved [543]
Atazanavir DMSYRBX Human immunodeficiency virus infection 1C62 Approved [542]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [194]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [465]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [149]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [191]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [105]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
cinnamaldehyde DMZDUXG Discovery agent N.A. Investigative [544]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Arsenic DMTL2Y1 N. A. N. A. Approved [545]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Cytarabine DMZD5QR Acute lymphoblastic leukaemia 2A85 Approved [321]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Sulindac DM2QHZU Acute myelogenous leukaemia 2A41 Approved [546]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Testosterone DM7HUNW Hot flushes GA30 Approved [134]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [478]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [103]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [547]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [78]
Quercetin DM3NC4M Obesity 5B81 Approved [239]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [138]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [151]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [124]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [216]
Rosiglitazone DMILWZR Chronic kidney disease GB61 Approved [386]
Dexamethasone DMMWZET Acute adrenal insufficiency Approved [157]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [62]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [154]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
THAPSIGARGIN DMDMQIE N. A. N. A. Preclinical [451]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [216]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By SPATS2-like protein (SPATS2L)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Methotrexate DM2TEOL Anterior urethra cancer Approved [133]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [138]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [110]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [548]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Syntabulin (SYBU)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [124]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [152]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [211]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [62]
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Zidovudine DM4KI7O Human immunodeficiency virus infection 1C62 Approved [123]
Testosterone DM7HUNW Hot flushes GA30 Approved [134]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Beta-carotene DM0RXBT Vitamin deficiency 5B55-5B71 Approved [549]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Testosterone DM7HUNW Hot flushes GA30 Approved [134]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [194]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [118]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [131]
Milchsaure DM462BT Pruritus EC90 Investigative [113]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Bortezomib DMNO38U Leukemia Approved [509]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [218]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [460]
Milchsaure DM462BT Pruritus EC90 Investigative [113]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [156]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [203]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [83]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [467]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Selenium DM25CGV N. A. N. A. Approved [83]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [550]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [152]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [191]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Niclosamide DMJAGXQ Cestodes infection 1F70-1F76 Approved [464]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Diethylstilbestrol DMN3UXQ Gonorrheal vaginitis GA02 Approved [103]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Carbamazepine DMZOLBI Epilepsy 8A60-8A68 Approved [173]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [475]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [95]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
COUMARIN DM0N8ZM Discovery agent N.A. Investigative [131]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [131]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Clorgyline DMCEUJD Parkinson disease 8A00.0 Approved [358]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [362]
Bortezomib DMNO38U Leukemia Approved [136]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [551]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [100]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Kelch-like protein 13 (KLHL13)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [110]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [211]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Triclosan DMZUR4N Malaria 1F40-1F45 Approved [117]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [187]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
THAPSIGARGIN DMDMQIE N. A. N. A. Preclinical [451]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [194]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [552]
Marinol DM70IK5 Anorexia nervosa cachexia 6B80 Approved [156]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Demecolcine DMCZQGK Solid tumour/cancer 2A00-2F9Z Approved [216]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Bortezomib DMNO38U Leukemia Approved [136]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [110]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Arsenic DMTL2Y1 N. A. N. A. Approved [553]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [218]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [467]
COUMESTROL DM40TBU Discovery agent N.A. Investigative [96]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [216]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [206]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [218]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [100]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Topotecan DMP6G8T Central nervous system neoplasm Approved [167]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [149]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
⏷ Show the Full List of 8 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Methotrexate DM2TEOL Anterior urethra cancer Approved [133]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Bortezomib DMNO38U Leukemia Approved [136]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [554]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [555]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [83]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Amiodarone DMUTEX3 Tachyarrhythmias BC71 Approved [291]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [556]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
Formaldehyde DM7Q6M0 Discovery agent N.A. Investigative [216]
Trichostatin A DM9C8NX Solid tumour/cancer 2A00-2F9Z Investigative [191]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [62]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [198]
chloropicrin DMSGBQA Discovery agent N.A. Investigative [409]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
PMID28870136-Compound-52 DMFDERP N. A. N. A. Patented [131]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
⏷ Show the Full List of 6 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Cannabidiol DM0659E Dravet syndrome 8A61.11 Approved [72]
Selenium DM25CGV N. A. N. A. Approved [83]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Panobinostat DM58WKG Chronic graft versus host disease Approved [109]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [536]
Hydroquinone DM6AVR4 Melasma ED60.1 Approved [557]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ethanol DMDRQZU Chronic pain MG30 Approved [558]
Menthol DMG2KW7 Back pain ME84.Z Approved [141]
⏷ Show the Full List of 10 Drug(s)
Drug(s) Affected By Sorting nexin-12 (SNX12)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Mifepristone DMGZQEF Cushing disease 5A70 Approved [401]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [157]
Milchsaure DM462BT Pruritus EC90 Investigative [113]
⏷ Show the Full List of 8 Drug(s)
Drug(s) Affected By Rab-like protein 2B (RABL2B)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [325]
Urethane DM7NSI0 N. A. N. A. Phase 4 [111]
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Zoledronate DMIXC7G Adenocarcinoma 2D40 Approved [211]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [100]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [157]
2-AMINO-1-METHYL-6-PHENYLIMIDAZO[4,5-B]PYRIDINE DMNQL17 Discovery agent N.A. Investigative [559]
⏷ Show the Full List of 9 Drug(s)
Drug(s) Affected By Dynamin-3 (DNM3)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [115]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [422]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Progesterone DMUY35B Amenorrhea GA20.0 Approved [474]
Phenobarbital DMXZOCG Cluster headache 8A81.0 Approved [486]
SNDX-275 DMH7W9X Breast cancer 2C60-2C65 Phase 3 [105]
(+)-JQ1 DM1CZSJ Testicular cancer 2C80 Phase 1 [118]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [62]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Troglitazone DM3VFPD Diabetic complication 5A2Y Approved [332]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [439]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [550]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [110]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Fluorouracil DMUM7HZ Adenocarcinoma 2D40 Approved [560]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Quercetin DM3NC4M Obesity 5B81 Approved [79]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Tocopherol DMBIJZ6 N. A. N. A. Phase 2 [83]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [561]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [390]
[3H]methyltrienolone DMTSGOW Discovery agent N.A. Investigative [562]
⏷ Show the Full List of 9 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Fulvestrant DM0YZC6 Breast cancer 2C60-2C65 Approved [62]
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cocaine DMSOX7I Anaesthesia 9A78.6 Approved [359]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
COUMESTROL DM40TBU Discovery agent N.A. Investigative [96]
crotylaldehyde DMTWRQI Discovery agent N.A. Investigative [563]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Selenium DM25CGV N. A. N. A. Approved [83]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [110]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Sodium lauryl sulfate DMLJ634 Constipation DD91.1 Approved [362]
Decitabine DMQL8XJ Acute myelogenous leukaemia 2A41 Approved [564]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [128]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [463]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Isotretinoin DM4QTBN Acne vulgaris ED80 Approved [169]
Arsenic trioxide DM61TA4 Acute lymphoblastic leukaemia 2A85 Approved [565]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [116]
Temozolomide DMKECZD Adenocarcinoma 2D40 Approved [94]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Irinotecan DMP6SC2 Adenocarcinoma 2D40 Approved [365]
Arsenic DMTL2Y1 N. A. N. A. Approved [461]
Estradiol DMUNTE3 Acne vulgaris ED80 Approved [174]
Bicalutamide DMZMSPF Prostate cancer 2C82.0 Approved [566]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Tretinoin DM49DUI Acne vulgaris ED80 Approved [102]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [109]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Acetaminophen DMUIE76 Allergic rhinitis CA08.0 Approved [143]
Doxorubicin DMVP5YE Acute myelogenous leukaemia 2A41 Approved [122]
Vorinostat DMWMPD4 Adult acute monocytic leukemia Approved [105]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [567]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Hydrogen peroxide DM1NG5W Infectious disease 1A00-CA43.1 Approved [97]
Aspirin DM672AH Acute coronary syndrome BA41 Approved [222]
Testosterone DM7HUNW Hot flushes GA30 Approved [184]
Calcitriol DM8ZVJ7 Congenital alopecia LC30 Approved [184]
LY2835219 DM93VBZ Breast cancer 2C60-2C65 Approved [272]
Leflunomide DMR8ONJ Arthritis FA20 Approved [164]
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [92]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Palbociclib DMD7L94 Breast cancer 2C60-2C65 Approved [272]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
⏷ Show the Full List of 10 Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Ciclosporin DMAZJFX Graft-versus-host disease 4B24 Approved [98]
Valproate DMCFE9I Epilepsy 8A60-8A68 Approved [93]
Ivermectin DMDBX5F Intestinal strongyloidiasis due to nematode parasite 1F6B Approved [125]
Cupric Sulfate DMP0NFQ Fungal infection 1F29-1F2F Approved [99]
Cisplatin DMRHGI9 Adenocarcinoma 2D40 Approved [153]
Arsenic DMTL2Y1 N. A. N. A. Approved [104]
Benzo(a)pyrene DMN7J43 N. A. N. A. Phase 1 [101]
PMID28460551-Compound-2 DM4DOUB N. A. N. A. Patented [106]
bisphenol A DM2ZLD7 Discovery agent N.A. Investigative [460]
⏷ Show the Full List of 9 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Carbonic anhydrase (CA) TTUNARX NOUNIPROTAC Inhibitor [2]
Carbonic anhydrase I (CA-I) TTHQPL7 CAH1_HUMAN Inhibitor [2]
Carbonic anhydrase II (CA-II) TTANPDJ CAH2_HUMAN Inhibitor [2]
Carbonic anhydrase IV (CA-IV) TTZHA0O CAH4_HUMAN Inhibitor [2]
Carbonic anhydrase IX (CA-IX) TT2LVK8 CAH9_HUMAN Inhibitor [2]
Carbonic anhydrase VI (CA-VI) TTCFSPE CAH6_HUMAN Inhibitor [2]
Carbonic anhydrase XII (CA-XII) TTSYM0R CAH12_HUMAN Inhibitor [2]
Carbonic anhydrase XIV (CA-XIV) TTEYTKG CAH14_HUMAN Inhibitor [2]
P-selectin (SELP) TTE5VG0 LYAM3_HUMAN Inhibitor [3]

Drug Off-Target (DOT)
DOT Name DOT ID UniProt ID Interaction REF
2-oxoglutarate and iron-dependent oxygenase JMJD4 (JMJD4) OTYZGH63 JMJD4_HUMAN Gene/Protein Processing [4]
3-ketodihydrosphingosine reductase (KDSR) OTCIES3H KDSR_HUMAN Gene/Protein Processing [4]
6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 3 (PFKFB3) OT25JBA3 F263_HUMAN Gene/Protein Processing [4]
A-kinase anchor protein 13 (AKAP13) OTOZAR14 AKP13_HUMAN Gene/Protein Processing [4]
Abl interactor 1 (ABI1) OT5H4M62 ABI1_HUMAN Gene/Protein Processing [4]
Actin-binding protein WASF1 OT8C9841 WASF1_HUMAN Gene/Protein Processing [4]
Actin-related protein 2/3 complex subunit 4 (ARPC4) OT0ZE01B ARPC4_HUMAN Gene/Protein Processing [4]
Activating molecule in BECN1-regulated autophagy protein 1 (AMBRA1) OTY0YGT9 AMRA1_HUMAN Gene/Protein Processing [4]
Acyl-CoA dehydrogenase family member 10 (ACAD10) OTFAG3M0 ACD10_HUMAN Gene/Protein Processing [4]
Adhesion G protein-coupled receptor B2 (ADGRB2) OTOCY7XY AGRB2_HUMAN Gene/Protein Processing [4]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 5549).
2 Carbonic anhydrase inhibitors. Inhibition of mammalian isoforms I-XIV with a series of natural product polyphenols and phenolic acids. Bioorg Med Chem. 2010 Mar 15;18(6):2159-2164.
3 Rational design of novel, potent small molecule pan-selectin antagonists. J Med Chem. 2007 Mar 22;50(6):1101-15.
4 Gene expression profile analysis of gallic acid-induced cell death process. Sci Rep. 2021 Aug 18;11(1):16743. doi: 10.1038/s41598-021-96174-1.
5 Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid. Bioorg Med Chem. 2008 Aug 1;16(15):7424-8.
6 Cloning, expression, post-translational modifications and inhibition studies on the latest mammalian carbonic anhydrase isoform, CA XV. J Med Chem. 2009 Feb 12;52(3):646-54.
7 Carbonic anhydrase inhibitors. Antioxidant polyphenols effectively inhibit mammalian isoforms I-XV. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5050-3.
8 Carbonic anhydrase inhibitors. Interaction of the antitumor sulfamate EMD 486019 with twelve mammalian carbonic anhydrase isoforms: Kinetic and X-r... Bioorg Med Chem Lett. 2008 Aug 1;18(15):4282-6.
9 An Antibody-Drug Conjugate Targeting MUC1-Associated Carbohydrate CA6 Shows Promising Antitumor Activities. Mol Cancer Ther. 2020 Aug;19(8):1660-1669.
10 Polyamines inhibit carbonic anhydrases by anchoring to the zinc-coordinated water molecule. J Med Chem. 2010 Aug 12;53(15):5511-22.
11 Deciphering the mechanism of carbonic anhydrase inhibition with coumarins and thiocoumarins. J Med Chem. 2010 Jan 14;53(1):335-44.
12 Crizanlizumab: First Approval. Drugs. 2020 Jan;80(1):79-84.
13 Deal watch: Pfizer deal for selectin inhibitor highlights potential of glycomimetic drugs. Nat Rev Drug Discov. 2011 Dec 1;10(12):890.
14 Analytical comparability demonstrated for an IgG4 molecule, inclacumab, following transfer of manufacturing responsibility from Roche to Global Blood Therapeutics. Expert Opin Biol Ther. 2022 Nov;22(11):1417-1428.
15 Adjunctive selectin blockade successfully reduces infarct size beyond thrombolysis in the electrolytic canine coronary artery model. Circulation. 1995 Aug 1;92(3):492-9.
16 Clinical pipeline report, company report or official report of Selexys Pharmaceuticals (2011).
17 rPSGL-1-Ig, a recombinant PSGL-1-Ig fusion protein, ameliorates LPS-induced acute lung injury in mice by inhibiting neutrophil migration. Cell Mol Biol (Noisy-le-grand). 2015 Feb 28;61(1):1-6.
18 Effect of PSI-697, a novel P-selectin inhibitor, on platelet-monocyte aggregate formation in humans. J Am Heart Assoc. 2013 Jan 28;2(1):e006007.
19 WO patent application no. 2001,0276,21, Competitive inhibition elisa for antibody detection.
20 Administration of an antibody to E-selectin in patients with septic shock. Crit Care Med. 1996 Feb;24(2):229-33.
21 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
22 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2597).
23 Understanding the Dual Inhibition of COX-2 and Carbonic Anhydrase-II by Celecoxib and CG100649 Using Density Functional Theory Calculations and other Molecular Modelling Approaches. Protein Pept Lett. 2015;22(10):903-12.
24 Sulfonamide linked neoglycoconjugates--a new class of inhibitors for cancer-associated carbonic anhydrases. J Med Chem. 2010 Apr 8;53(7):2913-26.
25 Carbonic anhydrase inhibitors. Inhibition studies of a coral secretory isoform by sulfonamides. Bioorg Med Chem. 2009 Jul 15;17(14):5054-8.
26 Localization of diuretic effects along the loop of Henle: an in vivo microperfusion study in rats. Clin Sci (Lond). 2000 Apr;98(4):481-8.
27 The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.
28 Selective effect of thiazides on the human osteoblast-like cell line MG-63. Kidney Int. 1996 Nov;50(5):1476-82.
29 Inhibition of carbonic anhydrases I and II by N-unsubstituted carbamate esters. J Biol Chem. 1992 Dec 15;267(35):25044-50.
30 Nature of the inhibition of carbonic anhydrase by acetazolamide and benzthiazide. J Pharmacol Exp Ther. 1961 Mar;131:271-4.
31 Carbonic anhydrase inhibitors: inhibition of the transmembrane isozyme XIV with sulfonamides. Bioorg Med Chem Lett. 2005 Sep 1;15(17):3828-33.
32 Carbonic anhydrase inhibitors: Inhibition of the new membrane-associated isoform XV with phenols. Bioorg Med Chem Lett. 2008 Jun 15;18(12):3593-6.
33 Carbonic anhydrase inhibitors. Interaction of indapamide and related diuretics with 12 mammalian isozymes and X-ray crystallographic studies for th... Bioorg Med Chem Lett. 2008 Apr 15;18(8):2567-73.
34 Carbonic anhydrase inhibitors: crystallographic and solution binding studies for the interaction of a boron-containing aromatic sulfamide with mamm... Bioorg Med Chem Lett. 2010 Jun 15;20(12):3601-5.
35 Carbonic anhydrase inhibitors as antitumor/antimetastatic agents: a patent review (2008-2018).Expert Opin Ther Pat. 2018 Oct;28(10):729-740.
36 Carbonic anhydrase inhibitors. Inhibition of the membrane-bound human and bovine isozymes IV with sulfonamides. Bioorg Med Chem Lett. 2005 Feb 15;15(4):1149-54.
37 Carbonic anhydrase inhibitors. Interaction of isozymes I, II, IV, V, and IX with carboxylates. Bioorg Med Chem Lett. 2005 Feb 1;15(3):573-8.
38 Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-assoc... Bioorg Med Chem Lett. 2004 Jan 5;14(1):217-23.
39 Potential role of (124)I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer. Biologics. 2012;6:395-407.
40 Carbonic anhydrase inhibitors. Inhibition of isozymes I, II, IV, V, and IX with anions isosteric and isoelectronic with sulfate, nitrate, and carbo... Bioorg Med Chem Lett. 2005 Feb 1;15(3):567-71.
41 Therapeutic mechanism and efficacy of the antibody-drug conjugate BAY 79-4620 targeting human carbonic anhydrase 9. Mol Cancer Ther. 2012 Feb;11(2):340-9.
42 Application of monoclonal antibody G250 recognizing carbonic anhydrase IX in renal cell carcinoma. Int J Mol Sci. 2013 May 29;14(6):11402-23.
43 Zidovudine induces S-phase arrest and cell cycle gene expression changes in human cells. Mutagenesis. 2005 Mar;20(2):139-46. doi: 10.1093/mutage/gei019. Epub 2005 Mar 22.
44 Cannabidiol Activates Neuronal Precursor Genes in Human Gingival Mesenchymal Stromal Cells. J Cell Biochem. 2017 Jun;118(6):1531-1546. doi: 10.1002/jcb.25815. Epub 2016 Dec 29.
45 Gene expression profiles with activation of the estrogen receptor alpha-selective estrogen receptor modulator complex in breast cancer cells expressing wild-type estrogen receptor. Cancer Res. 2002 Aug 1;62(15):4419-26.
46 Leptomycin B reduces primary and acquired resistance of gefitinib in lung cancer cells. Toxicol Appl Pharmacol. 2017 Nov 15;335:16-27. doi: 10.1016/j.taap.2017.09.017. Epub 2017 Sep 21.
47 BMN 673 (talazoparib): A potent PARP inhibitor for triple negative breast cancer with different genetic profile. J Biochem Mol Toxicol. 2019 May;33(5):e22286. doi: 10.1002/jbt.22286. Epub 2019 Jan 23.
48 Gene expression after treatment with hydrogen peroxide, menadione, or t-butyl hydroperoxide in breast cancer cells. Cancer Res. 2002 Nov 1;62(21):6246-54.
49 Bexarotene activates the p53/p73 pathway in human cutaneous T-cell lymphoma. Br J Dermatol. 2009 Mar;160(3):519-26. doi: 10.1111/j.1365-2133.2008.08931.x. Epub 2008 Nov 25.
50 Glucocorticoids induce G1 arrest of lymphoblastic cells through retinoblastoma protein Rb1 dephosphorylation in childhood acute lymphoblastic leukemia in vivo. Cancer Biol Ther. 2004 May;3(5):470-6. doi: 10.4161/cbt.3.5.838. Epub 2004 May 9.
51 Ciprofloxacin mediated cell growth inhibition, S/G2-M cell cycle arrest, and apoptosis in a human transitional cell carcinoma of the bladder cell line. Clin Cancer Res. 2000 Mar;6(3):891-900.
52 Utilization of CDKN1A/p21 gene for class discrimination of DNA damage-induced clastogenicity. Toxicology. 2014 Jan 6;315:8-16. doi: 10.1016/j.tox.2013.10.009. Epub 2013 Nov 6.
53 Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer. Endocr Relat Cancer. 2011 Apr 28;18(3):333-45. doi: 10.1530/ERC-10-0262. Print 2011 Jun.
54 Dasatinib (BMS-354825) selectively induces apoptosis in lung cancer cells dependent on epidermal growth factor receptor signaling for survival. Cancer Res. 2006 Jun 1;66(11):5542-8. doi: 10.1158/0008-5472.CAN-05-4620.
55 Methotrexate increases expression of cell cycle checkpoint genes via JNK activation. Arthritis Rheum. 2012 Jun;64(6):1780-9. doi: 10.1002/art.34342. Epub 2011 Dec 19.
56 Simvastatin inhibits growth via apoptosis and the induction of cell cycle arrest in human melanoma cells. Melanoma Res. 2008 Apr;18(2):85-94. doi: 10.1097/CMR.0b013e3282f60097.
57 The dual ErbB1/ErbB2 inhibitor, lapatinib (GW572016), cooperates with tamoxifen to inhibit both cell proliferation- and estrogen-dependent gene expression in antiestrogen-resistant breast cancer. Cancer Res. 2005 Jan 1;65(1):18-25.
58 Effects of structurally related flavonoids on cell cycle progression of human melanoma cells: regulation of cyclin-dependent kinases CDK2 and CDK1. Biochem Pharmacol. 2001 May 15;61(10):1205-15. doi: 10.1016/s0006-2952(01)00583-4.
59 Fluoxetine mediates G0/G1 arrest by inducing functional inhibition of cyclin dependent kinase subunit (CKS)1. Biochem Pharmacol. 2008 May 15;75(10):1924-34. doi: 10.1016/j.bcp.2008.02.013. Epub 2008 Feb 17.
60 Induction mechanism of apoptosis by troglitazone through peroxisome proliferator-activated receptor-gamma in gastric carcinoma cells. Anticancer Res. 2003 Jan-Feb;23(1A):267-73.
61 Down-regulation of CD44 contributes to the differentiation of HL-60 cells induced by ATRA or HMBA. Cell Mol Immunol. 2007 Feb;4(1):59-63.
62 DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. Clin Epigenetics. 2019 Oct 10;11(1):138. doi: 10.1186/s13148-019-0725-y.
63 The anti-cancer drug gefitinib accelerates Fas-mediated apoptosis by enhancing caspase-8 activation in cancer cells. J Toxicol Sci. 2019;44(6):435-440. doi: 10.2131/jts.44.435.
64 NF-B potentiates caspase independent hydrogen peroxide induced cell death. PLoS One. 2011 Feb 15;6(2):e16815. doi: 10.1371/journal.pone.0016815.
65 Carvedilol prevents epinephrine-induced apoptosis in human coronary artery endothelial cells: modulation of Fas/Fas ligand and caspase-3 pathway. Cardiovasc Res. 2000 Feb;45(3):788-94. doi: 10.1016/s0008-6363(99)00369-7.
66 Quercetin induces FasL-related apoptosis, in part, through promotion of histone H3 acetylation in human leukemia HL-60 cells. Oncol Rep. 2011 Feb;25(2):583-91. doi: 10.3892/or.2010.1097. Epub 2010 Dec 10.
67 Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model. Toxicol In Vitro. 2009 Oct;23(7):1387-95.
68 Non-nutritional sweeteners effects on endothelial vascular function. Toxicol In Vitro. 2020 Feb;62:104694. doi: 10.1016/j.tiv.2019.104694. Epub 2019 Oct 23.
69 Influence of antitumor drugs on the expression of Fas system in SW480 colon cancer cells. Eur J Gastroenterol Hepatol. 2006 Oct;18(10):1071-7. doi: 10.1097/01.meg.0000231750.68513.6c.
70 Acrolein enhances epigenetic modifications, FasL expression and hepatocyte toxicity induced by anti-HIV drug Zidovudine. Toxicol In Vitro. 2016 Sep;35:66-76. doi: 10.1016/j.tiv.2016.05.013. Epub 2016 May 26.
71 Rifampicin inhibits CD95-mediated apoptosis of Jurkat T cells via glucocorticoid receptors by modifying the expression of molecules regulating apoptosis. J Clin Immunol. 2002 Jan;22(1):37-47. doi: 10.1023/a:1014256603539.
72 Cannabidiol Modulates the Immunophenotype and Inhibits the Activation of the Inflammasome in Human Gingival Mesenchymal Stem Cells. Front Physiol. 2016 Nov 24;7:559. doi: 10.3389/fphys.2016.00559. eCollection 2016.
73 Regulation of ERRalpha gene expression by estrogen receptor agonists and antagonists in SKBR3 breast cancer cells: differential molecular mechanisms mediated by g protein-coupled receptor GPR30/GPER-1. Mol Endocrinol. 2010 May;24(5):969-80. doi: 10.1210/me.2009-0148. Epub 2010 Mar 8.
74 Evidence of securin-mediated resistance to gefitinib-induced apoptosis in human cancer cells. Chem Biol Interact. 2013 Apr 25;203(2):412-22. doi: 10.1016/j.cbi.2013.03.011. Epub 2013 Mar 22.
75 Effects of gonadotrophin-releasing hormone agonists on apoptosis of granulosa cells. Ann N Y Acad Sci. 2005 May;1042:531-7. doi: 10.1196/annals.1338.065.
76 K-RAS transformation in prostate epithelial cell overcomes H2O2-induced apoptosis via upregulation of gamma-glutamyltransferase-2. Toxicol In Vitro. 2012 Apr;26(3):429-34. doi: 10.1016/j.tiv.2012.01.013. Epub 2012 Jan 17.
77 Nitric oxide inhibits execution of apoptosis at two distinct ATP-dependent steps upstream and downstream of mitochondrial cytochrome c release. Biochem Biophys Res Commun. 1999 Apr 29;258(1):215-21. doi: 10.1006/bbrc.1999.0491.
78 The contribution of methotrexate exposure and host factors on transcriptional variance in human liver. Toxicol Sci. 2007 Jun;97(2):582-94.
79 Comparison of phenotypic and transcriptomic effects of false-positive genotoxins, true genotoxins and non-genotoxins using HepG2 cells. Mutagenesis. 2011 Sep;26(5):593-604.
80 Troglitazone induces cytotoxicity in part by promoting the degradation of peroxisome proliferator-activated receptor co-activator-1 protein. Br J Pharmacol. 2010 Oct;161(4):771-81. doi: 10.1111/j.1476-5381.2010.00900.x.
81 Under ambient UVA exposure, pefloxacin exhibits both immunomodulatory and genotoxic effects via multiple mechanisms. J Photochem Photobiol B. 2018 Jan;178:593-605. doi: 10.1016/j.jphotobiol.2017.12.014. Epub 2017 Dec 15.
82 -Carotene Induces Apoptosis in Human Esophageal Squamous Cell Carcinoma Cell Lines via the Cav-1/AKT/NF-B Signaling Pathway. J Biochem Mol Toxicol. 2016 Mar;30(3):148-57. doi: 10.1002/jbt.21773. Epub 2016 Jan 6.
83 Selenium and vitamin E: cell type- and intervention-specific tissue effects in prostate cancer. J Natl Cancer Inst. 2009 Mar 4;101(5):306-20.
84 Differential gene expression of sulindac-treated human breast epithelial cells. Int J Oncol. 2005 Dec;27(6):1727-36.
85 Suppression of RAGE as a basis of simvastatin-dependent plaque stabilization in type 2 diabetes. Arterioscler Thromb Vasc Biol. 2006 Dec;26(12):2716-23.
86 Prevention of deoxycholate-induced gastric apoptosis by aspirin: roles of NF-kappaB and PKC signaling. J Surg Res. 2008 Mar;145(1):66-73. doi: 10.1016/j.jss.2007.04.039. Epub 2007 Jul 20.
87 Peroxisome proliferator-activated receptor-gamma agonists inhibit respiratory syncytial virus-induced expression of intercellular adhesion molecule-1 in human lung epithelial cells. Immunology. 2007 May;121(1):71-81. doi: 10.1111/j.1365-2567.2006.02539.x.
88 Differential modulation of PI3-kinase/Akt pathway during all-trans retinoic acid- and Am80-induced HL-60 cell differentiation revealed by DNA microarray analysis. Biochem Pharmacol. 2004 Dec 1;68(11):2177-86.
89 Glucosamine regulation of LPS-mediated inflammation in human bronchial epithelial cells. Eur J Pharmacol. 2010 Jun 10;635(1-3):219-26. doi: 10.1016/j.ejphar.2010.02.044. Epub 2010 Mar 20.
90 Oxidative stress modulates theophylline effects on steroid responsiveness. Biochem Biophys Res Commun. 2008 Dec 19;377(3):797-802.
91 Transcriptomics hit the target: monitoring of ligand-activated and stress response pathways for chemical testing. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):7-18.
92 Comparison of HepG2 and HepaRG by whole-genome gene expression analysis for the purpose of chemical hazard identification. Toxicol Sci. 2010 May;115(1):66-79.
93 Integrative omics data analyses of repeated dose toxicity of valproic acid in vitro reveal new mechanisms of steatosis induction. Toxicology. 2018 Jan 15;393:160-170.
94 Temozolomide induces activation of Wnt/-catenin signaling in glioma cells via PI3K/Akt pathway: implications in glioma therapy. Cell Biol Toxicol. 2020 Jun;36(3):273-278. doi: 10.1007/s10565-019-09502-7. Epub 2019 Nov 22.
95 Multiple microRNAs function as self-protective modules in acetaminophen-induced hepatotoxicity in humans. Arch Toxicol. 2018 Feb;92(2):845-858.
96 Pleiotropic combinatorial transcriptomes of human breast cancer cells exposed to mixtures of dietary phytoestrogens. Food Chem Toxicol. 2009 Apr;47(4):787-95.
97 Global gene expression analysis reveals differences in cellular responses to hydroxyl- and superoxide anion radical-induced oxidative stress in caco-2 cells. Toxicol Sci. 2010 Apr;114(2):193-203. doi: 10.1093/toxsci/kfp309. Epub 2009 Dec 31.
98 Integrating multiple omics to unravel mechanisms of Cyclosporin A induced hepatotoxicity in vitro. Toxicol In Vitro. 2015 Apr;29(3):489-501.
99 Physiological and toxicological transcriptome changes in HepG2 cells exposed to copper. Physiol Genomics. 2009 Aug 7;38(3):386-401.
100 Reproducible chemical-induced changes in gene expression profiles in human hepatoma HepaRG cells under various experimental conditions. Toxicol In Vitro. 2009 Apr;23(3):466-75. doi: 10.1016/j.tiv.2008.12.018. Epub 2008 Dec 30.
101 Air pollution and DNA methylation alterations in lung cancer: A systematic and comparative study. Oncotarget. 2017 Jan 3;8(1):1369-1391. doi: 10.18632/oncotarget.13622.
102 Transcriptional and Metabolic Dissection of ATRA-Induced Granulocytic Differentiation in NB4 Acute Promyelocytic Leukemia Cells. Cells. 2020 Nov 5;9(11):2423. doi: 10.3390/cells9112423.
103 Identification of biomarkers and outcomes of endocrine disruption in human ovarian cortex using In Vitro Models. Toxicology. 2023 Feb;485:153425. doi: 10.1016/j.tox.2023.153425. Epub 2023 Jan 5.
104 Prenatal arsenic exposure and the epigenome: identifying sites of 5-methylcytosine alterations that predict functional changes in gene expression in newborn cord blood and subsequent birth outcomes. Toxicol Sci. 2015 Jan;143(1):97-106. doi: 10.1093/toxsci/kfu210. Epub 2014 Oct 10.
105 Definition of transcriptome-based indices for quantitative characterization of chemically disturbed stem cell development: introduction of the STOP-Toxukn and STOP-Toxukk tests. Arch Toxicol. 2017 Feb;91(2):839-864.
106 Cell-based two-dimensional morphological assessment system to predict cancer drug-induced cardiotoxicity using human induced pluripotent stem cell-derived cardiomyocytes. Toxicol Appl Pharmacol. 2019 Nov 15;383:114761. doi: 10.1016/j.taap.2019.114761. Epub 2019 Sep 15.
107 Transcriptome dynamics of alternative splicing events revealed early phase of apoptosis induced by methylparaben in H1299 human lung carcinoma cells. Arch Toxicol. 2020 Jan;94(1):127-140. doi: 10.1007/s00204-019-02629-w. Epub 2019 Nov 20.
108 Toxicogenomics of kojic acid on gene expression profiling of a375 human malignant melanoma cells. Biol Pharm Bull. 2006 Apr;29(4):655-69.
109 A transcriptome-based classifier to identify developmental toxicants by stem cell testing: design, validation and optimization for histone deacetylase inhibitors. Arch Toxicol. 2015 Sep;89(9):1599-618.
110 Integrative "-Omics" analysis in primary human hepatocytes unravels persistent mechanisms of cyclosporine A-induced cholestasis. Chem Res Toxicol. 2016 Dec 19;29(12):2164-2174.
111 Ethyl carbamate induces cell death through its effects on multiple metabolic pathways. Chem Biol Interact. 2017 Nov 1;277:21-32.
112 Inhibition of BRD4 attenuates tumor cell self-renewal and suppresses stem cell signaling in MYC driven medulloblastoma. Oncotarget. 2014 May 15;5(9):2355-71.
113 Transcriptional profiling of lactic acid treated reconstructed human epidermis reveals pathways underlying stinging and itch. Toxicol In Vitro. 2019 Jun;57:164-173.
114 Expression profile analysis of colon cancer cells in response to sulindac or aspirin. Biochem Biophys Res Commun. 2002 Mar 29;292(2):498-512.
115 Phenotypic characterization of retinoic acid differentiated SH-SY5Y cells by transcriptional profiling. PLoS One. 2013 May 28;8(5):e63862.
116 Human embryonic stem cell-derived test systems for developmental neurotoxicity: a transcriptomics approach. Arch Toxicol. 2013 Jan;87(1):123-43.
117 Transcriptome and DNA methylome dynamics during triclosan-induced cardiomyocyte differentiation toxicity. Stem Cells Int. 2018 Oct 29;2018:8608327.
118 CCAT1 is an enhancer-templated RNA that predicts BET sensitivity in colorectal cancer. J Clin Invest. 2016 Feb;126(2):639-52.
119 Exome-wide mutation profile in benzo[a]pyrene-derived post-stasis and immortal human mammary epithelial cells. Mutat Res Genet Toxicol Environ Mutagen. 2014 Dec;775-776:48-54. doi: 10.1016/j.mrgentox.2014.10.011. Epub 2014 Nov 4.
120 Development and validation of the TGx-HDACi transcriptomic biomarker to detect histone deacetylase inhibitors in human TK6 cells. Arch Toxicol. 2021 May;95(5):1631-1645. doi: 10.1007/s00204-021-03014-2. Epub 2021 Mar 26.
121 Low doses of cisplatin induce gene alterations, cell cycle arrest, and apoptosis in human promyelocytic leukemia cells. Biomark Insights. 2016 Aug 24;11:113-21.
122 Bringing in vitro analysis closer to in vivo: studying doxorubicin toxicity and associated mechanisms in 3D human microtissues with PBPK-based dose modelling. Toxicol Lett. 2018 Sep 15;294:184-192.
123 Differential gene expression in human hepatocyte cell lines exposed to the antiretroviral agent zidovudine. Arch Toxicol. 2014 Mar;88(3):609-23. doi: 10.1007/s00204-013-1169-3. Epub 2013 Nov 30.
124 Keratinocyte-derived IL-36gama plays a role in hydroquinone-induced chemical leukoderma through inhibition of melanogenesis in human epidermal melanocytes. Arch Toxicol. 2019 Aug;93(8):2307-2320.
125 Quantitative proteomics reveals a broad-spectrum antiviral property of ivermectin, benefiting for COVID-19 treatment. J Cell Physiol. 2021 Apr;236(4):2959-2975. doi: 10.1002/jcp.30055. Epub 2020 Sep 22.
126 2', 3'-Dideoxycytidine represses thymidine kinases 1 and 2 expression in T-lymphoid cells. Life Sci. 2004 Jan 2;74(7):835-42. doi: 10.1016/j.lfs.2003.07.023.
127 Drug-induced endoplasmic reticulum and oxidative stress responses independently sensitize toward TNF-mediated hepatotoxicity. Toxicol Sci. 2014 Jul;140(1):144-59. doi: 10.1093/toxsci/kfu072. Epub 2014 Apr 20.
128 Gene expression analysis of precision-cut human liver slices indicates stable expression of ADME-Tox related genes. Toxicol Appl Pharmacol. 2011 May 15;253(1):57-69.
129 Expression profiling of nucleotide metabolism-related genes in human breast cancer cells after treatment with 5-fluorouracil. Cancer Invest. 2009 Jun;27(5):561-7.
130 Inhibiting ubiquitination causes an accumulation of SUMOylated newly synthesized nuclear proteins at PML bodies. J Biol Chem. 2019 Oct 18;294(42):15218-15234. doi: 10.1074/jbc.RA119.009147. Epub 2019 Jul 8.
131 Quantitative phosphoproteomics reveal cellular responses from caffeine, coumarin and quercetin in treated HepG2 cells. Toxicol Appl Pharmacol. 2022 Aug 15;449:116110. doi: 10.1016/j.taap.2022.116110. Epub 2022 Jun 7.
132 Tea polyphenols ameliorates neural redox imbalance and mitochondrial dysfunction via mechanisms linking the key circadian regular Bmal1. Food Chem Toxicol. 2017 Dec;110:189-199. doi: 10.1016/j.fct.2017.10.031. Epub 2017 Oct 20.
133 Global molecular effects of tocilizumab therapy in rheumatoid arthritis synovium. Arthritis Rheumatol. 2014 Jan;66(1):15-23.
134 The exosome-like vesicles derived from androgen exposed-prostate stromal cells promote epithelial cells proliferation and epithelial-mesenchymal transition. Toxicol Appl Pharmacol. 2021 Jan 15;411:115384. doi: 10.1016/j.taap.2020.115384. Epub 2020 Dec 25.
135 Peripheral CLOCK regulates target-tissue glucocorticoid receptor transcriptional activity in a circadian fashion in man. PLoS One. 2011;6(9):e25612. doi: 10.1371/journal.pone.0025612. Epub 2011 Sep 28.
136 The proapoptotic effect of zoledronic acid is independent of either the bone microenvironment or the intrinsic resistance to bortezomib of myeloma cells and is enhanced by the combination with arsenic trioxide. Exp Hematol. 2011 Jan;39(1):55-65.
137 Glucocorticoids affect 24 h clock genes expression in human adipose tissue explant cultures. PLoS One. 2012;7(12):e50435. doi: 10.1371/journal.pone.0050435. Epub 2012 Dec 10.
138 Development of a neural teratogenicity test based on human embryonic stem cells: response to retinoic acid exposure. Toxicol Sci. 2011 Dec;124(2):370-7.
139 Arsenic trioxide induces different gene expression profiles of genes related to growth and apoptosis in glioma cells dependent on the p53 status. Mol Biol Rep. 2008 Sep;35(3):421-9.
140 Chronic ethanol exposure increases goosecoid (GSC) expression in human embryonic carcinoma cell differentiation. J Appl Toxicol. 2014 Jan;34(1):66-75.
141 Repurposing L-menthol for systems medicine and cancer therapeutics? L-menthol induces apoptosis through caspase 10 and by suppressing HSP90. OMICS. 2016 Jan;20(1):53-64.
142 Effects of paclitaxel on proliferation and apoptosis in human acute myeloid leukemia HL-60 cells. Acta Pharmacol Sin. 2004 Mar;25(3):378-84.
143 Blood transcript immune signatures distinguish a subset of people with elevated serum ALT from others given acetaminophen. Clin Pharmacol Ther. 2016 Apr;99(4):432-41.
144 Gene alterations of ovarian cancer cells expressing estrogen receptors by estrogen and bisphenol a using microarray analysis. Lab Anim Res. 2011 Jun;27(2):99-107. doi: 10.5625/lar.2011.27.2.99. Epub 2011 Jun 22.
145 Induction of class II major histocompatibility complex expression in human multiple myeloma cells by retinoid. Haematologica. 2007 Jan;92(1):115-20.
146 Targeting MYCN in neuroblastoma by BET bromodomain inhibition. Cancer Discov. 2013 Mar;3(3):308-23.
147 Molecular mechanisms of resveratrol action in lung cancer cells using dual protein and microarray analyses. Cancer Res. 2007 Dec 15;67(24):12007-17. doi: 10.1158/0008-5472.CAN-07-2464.
148 Proteomic analysis of the cellular response to a potent sensitiser unveils the dynamics of haptenation in living cells. Toxicology. 2020 Dec 1;445:152603. doi: 10.1016/j.tox.2020.152603. Epub 2020 Sep 28.
149 Effect of aflatoxin B(1), benzo[a]pyrene, and methapyrilene on transcriptomic and epigenetic alterations in human liver HepaRG cells. Food Chem Toxicol. 2018 Nov;121:214-223. doi: 10.1016/j.fct.2018.08.034. Epub 2018 Aug 26.
150 Microarray analysis of H2O2-, HNE-, or tBH-treated ARPE-19 cells. Free Radic Biol Med. 2002 Nov 15;33(10):1419-32.
151 Essential role of cell cycle regulatory genes p21 and p27 expression in inhibition of breast cancer cells by arsenic trioxide. Med Oncol. 2011 Dec;28(4):1225-54.
152 Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Mol Endocrinol. 2005 Nov;19(11):2685-95.
153 Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress. Toxicol Lett. 2016 Sep 6;258:227-236.
154 Epidermal growth factor receptor signalling in human breast cancer cells operates parallel to estrogen receptor alpha signalling and results in tamoxifen insensitive proliferation. BMC Cancer. 2014 Apr 23;14:283.
155 Gene expression profile changes in NB4 cells induced by arsenic trioxide. Acta Pharmacol Sin. 2003 Jul;24(7):646-50.
156 THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry. 2018 Apr 25;8(1):89. doi: 10.1038/s41398-018-0137-3.
157 Identification of mechanisms of action of bisphenol a-induced human preadipocyte differentiation by transcriptional profiling. Obesity (Silver Spring). 2014 Nov;22(11):2333-43.
158 Transcriptomic Analysis of Stem Cells Treated with Moringin or Cannabidiol: Analogies and Differences in Inflammation Pathways. Int J Mol Sci. 2019 Nov 30;20(23):6039. doi: 10.3390/ijms20236039.
159 Activation of nuclear factor-kappa B pathway by simvastatin and RhoA silencing increases doxorubicin cytotoxicity in human colon cancer HT29 cells. Mol Pharmacol. 2008 Aug;74(2):476-84.
160 A peptidyl-glucosamine derivative affects IKKalpha kinase activity in human chondrocytes. Arthritis Res Ther. 2010;12(1):R18. doi: 10.1186/ar2920. Epub 2010 Jan 29.
161 Arsenic trioxide exerts antimyeloma effects by inhibiting activity in the cytoplasmic substrates of histone deacetylase 6. PLoS One. 2012;7(2):e32215. doi: 10.1371/journal.pone.0032215. Epub 2012 Feb 22.
162 Constitutive activation of IkappaB kinase alpha and NF-kappaB in prostate cancer cells is inhibited by ibuprofen. Oncogene. 1999 Dec 2;18(51):7389-94. doi: 10.1038/sj.onc.1203160.
163 Antiepileptic drugs are endocrine disruptors for the human fetal testis ex vivo. Toxicol Sci. 2023 Sep 28;195(2):169-183. doi: 10.1093/toxsci/kfad076.
164 Endoplasmic reticulum stress and MAPK signaling pathway activation underlie leflunomide-induced toxicity in HepG2 Cells. Toxicology. 2017 Dec 1;392:11-21.
165 Bisphenol A Exposure Changes the Transcriptomic and Proteomic Dynamics of Human Retinoblastoma Y79 Cells. Genes (Basel). 2021 Feb 11;12(2):264. doi: 10.3390/genes12020264.
166 Neurotoxicity and underlying cellular changes of 21 mitochondrial respiratory chain inhibitors. Arch Toxicol. 2021 Feb;95(2):591-615. doi: 10.1007/s00204-020-02970-5. Epub 2021 Jan 29.
167 Gene expression profiling of 30 cancer cell lines predicts resistance towards 11 anticancer drugs at clinically achieved concentrations. Int J Cancer. 2006 Apr 1;118(7):1699-712. doi: 10.1002/ijc.21570.
168 Clarifying off-target effects for torcetrapib using network pharmacology and reverse docking approach. BMC Syst Biol. 2012 Dec 10;6:152.
169 Temporal changes in gene expression in the skin of patients treated with isotretinoin provide insight into its mechanism of action. Dermatoendocrinol. 2009 May;1(3):177-87.
170 Folic acid supplementation dysregulates gene expression in lymphoblastoid cells--implications in nutrition. Biochem Biophys Res Commun. 2011 Sep 9;412(4):688-92. doi: 10.1016/j.bbrc.2011.08.027. Epub 2011 Aug 16.
171 Pregnancy exposure to synthetic phenols and placental DNA methylation - An epigenome-wide association study in male infants from the EDEN cohort. Environ Pollut. 2021 Dec 1;290:118024. doi: 10.1016/j.envpol.2021.118024. Epub 2021 Aug 21.
172 DNA microarray analysis of vitamin D-induced gene expression in a human colon carcinoma cell line. Physiol Genomics. 2004 Apr 13;17(2):122-9. doi: 10.1152/physiolgenomics.00002.2003.
173 Gene Expression Regulation and Pathway Analysis After Valproic Acid and Carbamazepine Exposure in a Human Embryonic Stem Cell-Based Neurodevelopmental Toxicity Assay. Toxicol Sci. 2015 Aug;146(2):311-20. doi: 10.1093/toxsci/kfv094. Epub 2015 May 15.
174 Estradiol and selective estrogen receptor modulators differentially regulate target genes with estrogen receptors alpha and beta. Mol Biol Cell. 2004 Mar;15(3):1262-72. doi: 10.1091/mbc.e03-06-0360. Epub 2003 Dec 29.
175 Minimal peroxide exposure of neuronal cells induces multifaceted adaptive responses. PLoS One. 2010 Dec 17;5(12):e14352. doi: 10.1371/journal.pone.0014352.
176 Role of NADPH oxidase in arsenic-induced reactive oxygen species formation and cytotoxicity in myeloid leukemia cells. Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4578-83.
177 LSD1 activates a lethal prostate cancer gene network independently of its demethylase function. Proc Natl Acad Sci U S A. 2018 May 1;115(18):E4179-E4188.
178 Bone marrow osteoblast damage by chemotherapeutic agents. PLoS One. 2012;7(2):e30758. doi: 10.1371/journal.pone.0030758. Epub 2012 Feb 17.
179 Inhibition of CXCL12-mediated chemotaxis of Jurkat cells by direct immunotoxicants. Arch Toxicol. 2016 Jul;90(7):1685-94. doi: 10.1007/s00204-015-1585-7. Epub 2015 Aug 28.
180 Gene expression changes in primary human nasal epithelial cells exposed to formaldehyde in vitro. Toxicol Lett. 2010 Oct 5;198(2):289-95.
181 Arsenic suppresses gene expression in promyelocytic leukemia cells partly through Sp1 oxidation. Blood. 2005 Jul 1;106(1):304-10.
182 Transcriptional profiling of testosterone-regulated genes in the skeletal muscle of human immunodeficiency virus-infected men experiencing weight loss. J Clin Endocrinol Metab. 2007 Jul;92(7):2793-802. doi: 10.1210/jc.2006-2722. Epub 2007 Apr 17.
183 Coordinate up-regulation of TMEM97 and cholesterol biosynthesis genes in normal ovarian surface epithelial cells treated with progesterone: implications for pathogenesis of ovarian cancer. BMC Cancer. 2007 Dec 11;7:223.
184 Effects of 1alpha,25 dihydroxyvitamin D3 and testosterone on miRNA and mRNA expression in LNCaP cells. Mol Cancer. 2011 May 18;10:58.
185 The neuroprotective action of the mood stabilizing drugs lithium chloride and sodium valproate is mediated through the up-regulation of the homeodomain protein Six1. Toxicol Appl Pharmacol. 2009 Feb 15;235(1):124-34.
186 Comprehensive transcriptome profiling of BET inhibitor-treated HepG2 cells. PLoS One. 2022 Apr 29;17(4):e0266966. doi: 10.1371/journal.pone.0266966. eCollection 2022.
187 Identification of a transcriptomic signature of food-relevant genotoxins in human HepaRG hepatocarcinoma cells. Food Chem Toxicol. 2020 Jun;140:111297. doi: 10.1016/j.fct.2020.111297. Epub 2020 Mar 28.
188 Characterization of the Molecular Alterations Induced by the Prolonged Exposure of Normal Colon Mucosa and Colon Cancer Cells to Low-Dose Bisphenol A. Int J Mol Sci. 2022 Oct 1;23(19):11620. doi: 10.3390/ijms231911620.
189 Motexafin gadolinium and zinc induce oxidative stress responses and apoptosis in B-cell lymphoma lines. Cancer Res. 2005 Dec 15;65(24):11676-88.
190 Design principles of concentration-dependent transcriptome deviations in drug-exposed differentiating stem cells. Chem Res Toxicol. 2014 Mar 17;27(3):408-20.
191 From transient transcriptome responses to disturbed neurodevelopment: role of histone acetylation and methylation as epigenetic switch between reversible and irreversible drug effects. Arch Toxicol. 2014 Jul;88(7):1451-68.
192 Global effects of inorganic arsenic on gene expression profile in human macrophages. Mol Immunol. 2009 Feb;46(4):649-56.
193 Apoptosis induced by piroxicam plus cisplatin combined treatment is triggered by p21 in mesothelioma. PLoS One. 2011;6(8):e23569.
194 17-Estradiol Activates HSF1 via MAPK Signaling in ER-Positive Breast Cancer Cells. Cancers (Basel). 2019 Oct 11;11(10):1533. doi: 10.3390/cancers11101533.
195 Gene expression in endometrial cancer cells (Ishikawa) after short time high dose exposure to progesterone. Steroids. 2008 Jan;73(1):116-28.
196 Single-cell Transcriptome Mapping Identifies Common and Cell-type Specific Genes Affected by Acute Delta9-tetrahydrocannabinol in Humans. Sci Rep. 2020 Feb 26;10(1):3450. doi: 10.1038/s41598-020-59827-1.
197 Growth inhibition and induction of apoptosis in mesothelioma cells by selenium and dependence on selenoprotein SEP15 genotype. Oncogene. 2004 Jun 24;23(29):5032-40. doi: 10.1038/sj.onc.1207683.
198 Environmental pollutant induced cellular injury is reflected in exosomes from placental explants. Placenta. 2020 Jan 1;89:42-49. doi: 10.1016/j.placenta.2019.10.008. Epub 2019 Oct 17.
199 ST1926, a novel and orally active retinoid-related molecule inducing apoptosis in myeloid leukemia cells: modulation of intracellular calcium homeostasis. Blood. 2004 Jan 1;103(1):194-207.
200 Molecular targets of chloropicrin in human airway epithelial cells. Toxicol In Vitro. 2017 Aug;42:247-254.
201 PGK1 induction by a hydrogen peroxide treatment is suppressed by antioxidants in human colon carcinoma cells. Biosci Biotechnol Biochem. 2008 Jul;72(7):1799-808. doi: 10.1271/bbb.80079. Epub 2008 Jul 7.
202 The NRF2-mediated oxidative stress response pathway is associated with tumor cell resistance to arsenic trioxide across the NCI-60 panel. BMC Med Genomics. 2010 Aug 13;3:37. doi: 10.1186/1755-8794-3-37.
203 Acute hypersensitivity of pluripotent testicular cancer-derived embryonal carcinoma to low-dose 5-aza deoxycytidine is associated with global DNA Damage-associated p53 activation, anti-pluripotency and DNA demethylation. PLoS One. 2012;7(12):e53003. doi: 10.1371/journal.pone.0053003. Epub 2012 Dec 27.
204 The thioxotriazole copper(II) complex A0 induces endoplasmic reticulum stress and paraptotic death in human cancer cells. J Biol Chem. 2009 Sep 4;284(36):24306-19.
205 Unique transcriptome, pathways, and networks in the human endometrial fibroblast response to progesterone in endometriosis. Biol Reprod. 2011 Apr;84(4):801-15.
206 Predictive toxicology using systemic biology and liver microfluidic "on chip" approaches: application to acetaminophen injury. Toxicol Appl Pharmacol. 2012 Mar 15;259(3):270-80.
207 Imatinib disturbs lysosomal function and morphology and impairs the activity of mTORC1 in human hepatocyte cell lines. Food Chem Toxicol. 2022 Apr;162:112869. doi: 10.1016/j.fct.2022.112869. Epub 2022 Feb 16.
208 Label-free quantitative proteomic analysis identifies the oncogenic role of FOXA1 in BaP-transformed 16HBE cells. Toxicol Appl Pharmacol. 2020 Sep 15;403:115160. doi: 10.1016/j.taap.2020.115160. Epub 2020 Jul 25.
209 Suppressed translation and ULK1 degradation as potential mechanisms of autophagy limitation under prolonged starvation. Autophagy. 2016 Nov;12(11):2085-2097. doi: 10.1080/15548627.2016.1226733. Epub 2016 Sep 14.
210 Chronic occupational exposure to arsenic induces carcinogenic gene signaling networks and neoplastic transformation in human lung epithelial cells. Toxicol Appl Pharmacol. 2012 Jun 1;261(2):204-16.
211 Interleukin-19 as a translational indicator of renal injury. Arch Toxicol. 2015 Jan;89(1):101-6.
212 Chronic cyclophosphamide exposure alters the profile of rat sperm nuclear matrix proteins. Biol Reprod. 2007 Aug;77(2):303-11. doi: 10.1095/biolreprod.107.060244. Epub 2007 May 2.
213 Darinaparsin induces a unique cellular response and is active in an arsenic trioxide-resistant myeloma cell line. Mol Cancer Ther. 2009 May;8(5):1197-206.
214 Mutant p53 reactivation by PRIMA-1MET induces multiple signaling pathways converging on apoptosis. Oncogene. 2010 Mar 4;29(9):1329-38. doi: 10.1038/onc.2009.425. Epub 2009 Nov 30.
215 Glyphosate-based herbicides at low doses affect canonical pathways in estrogen positive and negative breast cancer cell lines. PLoS One. 2019 Jul 11;14(7):e0219610. doi: 10.1371/journal.pone.0219610. eCollection 2019.
216 Characterization of formaldehyde's genotoxic mode of action by gene expression analysis in TK6 cells. Arch Toxicol. 2013 Nov;87(11):1999-2012.
217 Human 3D multicellular microtissues: an upgraded model for the in vitro mechanistic investigation of inflammation-associated drug toxicity. Toxicol Lett. 2019 Sep 15;312:34-44.
218 Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of sites in a cell type-specific manner. Genome Res. 2012 Nov;22(11):2153-62.
219 PPARgamma controls CD1d expression by turning on retinoic acid synthesis in developing human dendritic cells. J Exp Med. 2006 Oct 2;203(10):2351-62.
220 Sertraline induces endoplasmic reticulum stress in hepatic cells. Toxicology. 2014 Aug 1;322:78-88. doi: 10.1016/j.tox.2014.05.007. Epub 2014 May 24.
221 Functional gene expression profile underlying methotrexate-induced senescence in human colon cancer cells. Tumour Biol. 2011 Oct;32(5):965-76.
222 Expression profile analysis of human peripheral blood mononuclear cells in response to aspirin. Arch Immunol Ther Exp (Warsz). 2005 Mar-Apr;53(2):151-8.
223 Preparation and reactions of myoglobin mutants bearing both proximal cysteine ligand and hydrophobic distal cavity: protein models for the active site of P-450. Biochemistry. 1996 Oct 8;35(40):13118-24. doi: 10.1021/bi960459z.
224 Midazolam pretreatment does not ameliorate myoglobinemia or the clinical side effects of succinylcholine. J Clin Anesth. 1993 Sep-Oct;5(5):414-8. doi: 10.1016/0952-8180(93)90107-p.
225 Long-term estrogen exposure promotes carcinogen bioactivation, induces persistent changes in gene expression, and enhances the tumorigenicity of MCF-7 human breast cancer cells. Toxicol Appl Pharmacol. 2009 Nov 1;240(3):355-66.
226 Functional cardiotoxicity assessment of cosmetic compounds using human-induced pluripotent stem cell-derived cardiomyocytes. Arch Toxicol. 2018 Jan;92(1):371-381.
227 ADReCS-Target: target profiles for aiding drug safety research and application. Nucleic Acids Res. 2018 Jan 4;46(D1):D911-D917. doi: 10.1093/nar/gkx899.
228 Proteomics-based identification of differentially abundant proteins from human keratinocytes exposed to arsenic trioxide. J Proteomics Bioinform. 2014 Jul;7(7):166-178.
229 Analysis of gene expression induced by diethylstilbestrol (DES) in human primitive Mullerian duct cells using microarray. Cancer Lett. 2005 Apr 8;220(2):197-210.
230 MiR-99a and MiR-491 Regulate Cisplatin Resistance in Human Gastric Cancer Cells by Targeting CAPNS1. Int J Biol Sci. 2016 Nov 5;12(12):1437-1447. doi: 10.7150/ijbs.16529. eCollection 2016.
231 Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells. Gynecol Oncol. 2005 Jul;98(1):45-53. doi: 10.1016/j.ygyno.2005.04.010.
232 The genomic response of a human uterine endometrial adenocarcinoma cell line to 17alpha-ethynyl estradiol. Toxicol Sci. 2009 Jan;107(1):40-55.
233 Proteomic and functional analyses reveal a dual molecular mechanism underlying arsenic-induced apoptosis in human multiple myeloma cells. J Proteome Res. 2009 Jun;8(6):3006-19.
234 Cannabidiol Displays Proteomic Similarities to Antipsychotics in Cuprizone-Exposed Human Oligodendrocytic Cell Line MO3.13. Front Mol Neurosci. 2021 May 28;14:673144. doi: 10.3389/fnmol.2021.673144. eCollection 2021.
235 Mesalamine suppresses the expression of TC22, a novel tropomyosin isoform associated with colonic neoplasia. Mol Pharmacol. 2009 Jul;76(1):183-91. doi: 10.1124/mol.109.056028. Epub 2009 Apr 15.
236 Synergistic effect of trichostatin A and 5-aza-2'-deoxycytidine on growth inhibition of pancreatic endocrine tumour cell lines: a proteomic study. Proteomics. 2009 Apr;9(7):1952-66. doi: 10.1002/pmic.200701089.
237 Cannabidiol Modulates the Expression of Alzheimer's Disease-Related Genes in Mesenchymal Stem Cells. Int J Mol Sci. 2016 Dec 23;18(1):26. doi: 10.3390/ijms18010026.
238 [Simvastatin-induced apoptosis of K562 cells is mediated by endoplasmic reticulum stress]. Yao Xue Xue Bao. 2008 Apr;43(4):371-7.
239 Quercetin induced cell apoptosis and altered gene expression in AGS human gastric cancer cells. Environ Toxicol. 2018 Nov;33(11):1168-1181. doi: 10.1002/tox.22623. Epub 2018 Aug 27.
240 A potential role of calpains in sulfonylureas (SUs) -mediated death of human pancreatic cancer cells (1.2B4). Toxicol In Vitro. 2021 Jun;73:105128. doi: 10.1016/j.tiv.2021.105128. Epub 2021 Feb 27.
241 Endoplasmic reticulum stress contributes to arsenic trioxide-induced intrinsic apoptosis in human umbilical and bone marrow mesenchymal stem cells. Environ Toxicol. 2016 Mar;31(3):314-28.
242 Aspirin Has Antitumor Effects via Expression of Calpain Gene in Cervical Cancer Cells. J Oncol. 2008;2008:285374. doi: 10.1155/2008/285374. Epub 2008 Sep 29.
243 Anticancer effects of cantharidin in A431 human skin cancer (Epidermoid carcinoma) cells in vitro and in vivo. Environ Toxicol. 2017 Mar;32(3):723-738. doi: 10.1002/tox.22273. Epub 2016 Apr 25.
244 Arsenic trioxide (As(2)O(3)) induced apoptosis and its mechanisms in a human esophageal squamous carcinoma cell line. Chin Med J (Engl). 2002 Feb;115(2):280-5.
245 Arsenite and cadmium promote the development of mammary tumors. Carcinogenesis. 2020 Jul 14;41(7):1005-1014. doi: 10.1093/carcin/bgz176.
246 Reactive metabolite of gefitinib activates inflammasomes: implications for gefitinib-induced idiosyncratic reaction. J Toxicol Sci. 2020;45(11):673-680. doi: 10.2131/jts.45.673.
247 Simvastatin induces heat shock factor 1 in vascular endothelial cells. Atherosclerosis. 2006 Oct;188(2):265-73. doi: 10.1016/j.atherosclerosis.2005.10.045. Epub 2005 Dec 20.
248 Quantitative proteomic analysis of HepG2 cells treated with quercetin suggests IQGAP1 involved in quercetin-induced regulation of cell proliferation and migration. OMICS. 2009 Apr;13(2):93-103. doi: 10.1089/omi.2008.0075.
249 Gene expression changes in human small airway epithelial cells exposed to Delta9-tetrahydrocannabinol. Toxicol Lett. 2005 Aug 14;158(2):95-107.
250 Characteristics of P388/VMDRC.04, a simple, sensitive model for studying P-glycoprotein antagonists. Cancer Res. 1994 Feb 1;54(3):730-7.
251 Michaelis-Menten kinetic analysis of drugs of abuse to estimate their affinity to human P-glycoprotein. Toxicol Lett. 2013 Feb 27;217(2):137-42. doi: 10.1016/j.toxlet.2012.12.012. Epub 2012 Dec 27.
252 Editor's Highlight: PlacentalDisposition and Effects of Crizotinib: An Ex Vivo Study in the Isolated Dual-Side Perfused Human Cotyledon. Toxicol Sci. 2017 Jun 1;157(2):500-509. doi: 10.1093/toxsci/kfx063.
253 Functional evaluation of polymorphisms in the human ABCB1 gene and the impact on clinical responses of antiepileptic drugs. Pharmacogenet Genomics. 2008 May;18(5):390-402. doi: 10.1097/FPC.0b013e3282f85e36.
254 Cepharanthine potently enhances the sensitivity of anticancer agents in K562 cells. Cancer Sci. 2005 Jun;96(6):372-6. doi: 10.1111/j.1349-7006.2005.00057.x.
255 Clinical pharmacokinetic monitoring of itraconazole is warranted in only a subset of patients. Ther Drug Monit. 2005 Jun;27(3):322-33. doi: 10.1097/01.ftd.0000150135.22645.ea.
256 Evaluation of antipsychotic drugs as inhibitors of multidrug resistance transporter P-glycoprotein. Psychopharmacology (Berl). 2006 Sep;187(4):415-23. doi: 10.1007/s00213-006-0437-9. Epub 2006 Jun 30.
257 Actions of the selective protein kinase C inhibitor PKC412 on B-chronic lymphocytic leukemia cells in vitro. Haematologica. 2002 Feb;87(2):167-76.
258 Characterization of the ATPase activity of the Mr 170,000 to 180,000 membrane glycoprotein (P-glycoprotein) associated with multidrug resistance in K562/ADM cells. Cancer Res. 1988 Sep 1;48(17):4926-32.
259 Combination of imatinib and clotrimazole enhances cell growth inhibition in T47D breast cancer cells. Chem Biol Interact. 2015 May 25;233:147-56. doi: 10.1016/j.cbi.2015.03.028. Epub 2015 Apr 8.
260 Growth inhibition of ovarian tumor-initiating cells by niclosamide. Mol Cancer Ther. 2012 Aug;11(8):1703-12.
261 Gene expression profile induced by BCNU in human glioma cell lines with differential MGMT expression. J Neurooncol. 2005 Jul;73(3):189-98.
262 Resveratrol decreases breast cancer cell viability and glucose metabolism by inhibiting 6-phosphofructo-1-kinase. Biochimie. 2013 Jun;95(6):1336-43. doi: 10.1016/j.biochi.2013.02.013. Epub 2013 Feb 27.
263 Synthetic oleanane triterpenoid derivative CDDO-Me disrupts cellular bioenergetics to suppress pancreatic ductal adenocarcinoma via targeting SLC1A5. J Biochem Mol Toxicol. 2022 Nov;36(11):e23192. doi: 10.1002/jbt.23192. Epub 2022 Aug 5.
264 ROS-dependent DNA damage contributes to crizotinib-induced hepatotoxicity via the apoptotic pathway. Toxicol Appl Pharmacol. 2019 Nov 15;383:114768. doi: 10.1016/j.taap.2019.114768. Epub 2019 Oct 19.
265 Antitumor action of the MET tyrosine kinase inhibitor crizotinib (PF-02341066) in gastric cancer positive for MET amplification. Mol Cancer Ther. 2012 Jul;11(7):1557-64. doi: 10.1158/1535-7163.MCT-11-0934. Epub 2012 Jun 22.
266 An in vitro coculture system of human peripheral blood mononuclear cells with hepatocellular carcinoma-derived cells for predicting drug-induced liver injury. Arch Toxicol. 2021 Jan;95(1):149-168. doi: 10.1007/s00204-020-02882-4. Epub 2020 Aug 20.
267 Antirheumatic drug response signatures in human chondrocytes: potential molecular targets to stimulate cartilage regeneration. Arthritis Res Ther. 2009;11(1):R15.
268 All-trans retinoic acid inhibits the cell proliferation but enhances the cell invasion through up-regulation of c-met in pancreatic cancer cells. Cancer Lett. 2005 Jun 28;224(2):303-10. doi: 10.1016/j.canlet.2004.10.016. Epub 2004 Dec 8.
269 Retinoic acid can induce markers of endocrine transdifferentiation in pancreatic ductal adenocarcinoma: preliminary observations from an in vitro cell line model. J Clin Pathol. 2006 Jun;59(6):603-10. doi: 10.1136/jcp.2005.032003. Epub 2006 Feb 10.
270 Using a customized DNA microarray for expression profiling of the estrogen-responsive genes to evaluate estrogen activity among natural estrogens and industrial chemicals. Environ Health Perspect. 2004 May;112(7):773-81. doi: 10.1289/ehp.6753.
271 [Toxic effects of aluminum on human embryonic cerebral neurocytes in vitro studies]. Zhonghua Yu Fang Yi Xue Za Zhi. 2000 Mar;34(2):106-8.
272 Biological specificity of CDK4/6 inhibitors: dose response relationship, in vivo signaling, and composite response signature. Oncotarget. 2017 Jul 4;8(27):43678-43691. doi: 10.18632/oncotarget.18435.
273 Nobiletin, a citrus flavonoid, down-regulates matrix metalloproteinase-7 (matrilysin) expression in HT-29 human colorectal cancer cells. Biosci Biotechnol Biochem. 2005 Feb;69(2):307-14. doi: 10.1271/bbb.69.307.
274 Effect of retinoic acid on gene expression in human conjunctival epithelium: secretory phospholipase A2 mediates retinoic acid induction of MUC16. Invest Ophthalmol Vis Sci. 2005 Nov;46(11):4050-61.
275 Identification of vitamin D3 target genes in human breast cancer tissue. J Steroid Biochem Mol Biol. 2016 Nov;164:90-97.
276 The differential cancer growth associated with anaesthetics in a cancer xenograft model of mice: mechanisms and implications of postoperative cancer recurrence. Cell Biol Toxicol. 2023 Aug;39(4):1561-1575. doi: 10.1007/s10565-022-09747-9. Epub 2022 Aug 12.
277 Effect of mood stabilizers on gene expression in lymphoblastoid cells. J Neural Transm (Vienna). 2010 Feb;117(2):155-64.
278 Histamine H4 receptor agonists have more activities than H4 agonism in antigen-specific human T-cell responses. Immunology. 2007 Jun;121(2):266-75. doi: 10.1111/j.1365-2567.2007.02574.x. Epub 2007 Mar 7.
279 AMPK-dependent signaling modulates the suppression of invasion and migration by fenofibrate in CAL 27 oral cancer cells through NF-B pathway. Environ Toxicol. 2016 Jul;31(7):866-76. doi: 10.1002/tox.22097. Epub 2014 Dec 24.
280 Cannabidiol enhances cytotoxicity of anti-cancer drugs in human head and neck squamous cell carcinoma. Sci Rep. 2020 Nov 26;10(1):20622. doi: 10.1038/s41598-020-77674-y.
281 Cigarette smoke and asbestos activate poly-ADP-ribose polymerase in alveolar epithelial cells. J Investig Med. 2001 Jan;49(1):68-76. doi: 10.2310/6650.2001.34092.
282 Apoptotic signaling pathways induced by nitric oxide in human lymphoblastoid cells expressing wild-type or mutant p53. Cancer Res. 2004 May 1;64(9):3022-9. doi: 10.1158/0008-5472.can-03-1880.
283 The antidepressants imipramine, clomipramine, and citalopram induce apoptosis in human acute myeloid leukemia HL-60 cells via caspase-3 activation. J Biochem Mol Toxicol. 1999;13(6):338-47. doi: 10.1002/(sici)1099-0461(1999)13:6<338::aid-jbt8>3.0.co;2-7.
284 Investigation of molecular mechanisms underlying the antiproliferative effects of colchicine against PC3 prostate cancer cells. Toxicol In Vitro. 2021 Jun;73:105138. doi: 10.1016/j.tiv.2021.105138. Epub 2021 Mar 6.
285 Sulindac enhances adenoviral vector expressing mda-7/IL-24-mediated apoptosis in human lung cancer. Mol Cancer Ther. 2005 Feb;4(2):291-304.
286 Methotrexate induces poly(ADP-ribose) polymerase-dependent, caspase 3-independent apoptosis in subsets of proliferating CD4+ T cells. Clin Exp Immunol. 2007 May;148(2):288-95. doi: 10.1111/j.1365-2249.2007.03335.x. Epub 2007 Feb 7.
287 Quercetin suppresses pancreatic ductal adenocarcinoma progression via inhibition of SHH and TGF-/Smad signaling pathways. Cell Biol Toxicol. 2021 Jun;37(3):479-496. doi: 10.1007/s10565-020-09562-0. Epub 2020 Oct 17.
288 Hedgehog signaling antagonist GDC-0449 (Vismodegib) inhibits pancreatic cancer stem cell characteristics: molecular mechanisms. PLoS One. 2011;6(11):e27306. doi: 10.1371/journal.pone.0027306. Epub 2011 Nov 8.
289 Arsenic trioxide prevents osteosarcoma growth by inhibition of GLI transcription via DNA damage accumulation. PLoS One. 2013 Jul 8;8(7):e69466. doi: 10.1371/journal.pone.0069466. Print 2013.
290 DNA methylation inhibits p53-mediated survivin repression. Oncogene. 2009 May 14;28(19):2046-50. doi: 10.1038/onc.2009.62. Epub 2009 Apr 13.
291 Identification by automated screening of a small molecule that selectively eliminates neural stem cells derived from hESCs but not dopamine neurons. PLoS One. 2009 Sep 23;4(9):e7155.
292 Comparative gene expression profiling reveals partially overlapping but distinct genomic actions of different antiestrogens in human breast cancer cells. J Cell Biochem. 2006 Aug 1;98(5):1163-84.
293 Consequences of the natural retinoid/retinoid X receptor ligands action in human breast cancer MDA-MB-231 cell line: Focus on functional proteomics. Toxicol Lett. 2017 Nov 5;281:26-34. doi: 10.1016/j.toxlet.2017.09.001. Epub 2017 Sep 5.
294 Identification of biomarkers for the initiation of apoptosis in human preneoplastic colonocytes by proteome analysis. Int J Cancer. 2004 Mar 20;109(2):220-9. doi: 10.1002/ijc.11692.
295 Pharmacogenomic analysis of acute promyelocytic leukemia cells highlights CYP26 cytochrome metabolism in differential all-trans retinoic acid sensitivity. Blood. 2007 May 15;109(10):4450-60.
296 Indomethacin and ibuprofen induce Hsc70 nuclear localization and activation of the heat shock response in HeLa cells. Biochem Biophys Res Commun. 2004 Jan 23;313(4):863-70. doi: 10.1016/j.bbrc.2003.12.018.
297 Epigenetic silencing of novel tumor suppressors in malignant melanoma. Cancer Res. 2006 Dec 1;66(23):11187-93. doi: 10.1158/0008-5472.CAN-06-1274.
298 The effect of DNA methylation inhibitor 5-Aza-2'-deoxycytidine on human endometrial stromal cells. Hum Reprod. 2010 Nov;25(11):2859-69.
299 Exposure to Insecticides Modifies Gene Expression and DNA Methylation in Hematopoietic Tissues In Vitro. Int J Mol Sci. 2023 Mar 26;24(7):6259. doi: 10.3390/ijms24076259.
300 Integrated assessment by multiple gene expression analysis of quercetin bioactivity on anticancer-related mechanisms in colon cancer cells in vitro. Eur J Nutr. 2005 Mar;44(3):143-56. doi: 10.1007/s00394-004-0503-1. Epub 2004 Apr 30.
301 Taurine improves low-level inorganic arsenic-induced insulin resistance by activating PPAR-mTORC2 signalling and inhibiting hepatic autophagy. J Cell Physiol. 2019 Apr;234(4):5143-5152. doi: 10.1002/jcp.27318. Epub 2018 Oct 26.
302 Testosterone or 17{beta}-estradiol exposure reveals sex-specific effects on glucose and lipid metabolism in human myotubes. J Endocrinol. 2011 Aug;210(2):219-29. doi: 10.1530/JOE-10-0497. Epub 2011 Jun 1.
303 Mechanisms of the genotoxicity of crocidolite asbestos in mammalian cells: implication from mutation patterns induced by reactive oxygen species. Environ Health Perspect. 2002 Oct;110(10):1003-8. doi: 10.1289/ehp.021101003.
304 Comparison of the mutagenic potential of 17 physical and chemical agents analyzed by the flow cytometry mutation assay. Mutat Res. 2006 Dec 1;602(1-2):14-25. doi: 10.1016/j.mrfmmm.2006.07.009. Epub 2006 Oct 11.
305 Differential regulation of sinusoidal and canalicular hepatic drug transporter expression by xenobiotics activating drug-sensing receptors in primary human hepatocytes. Drug Metab Dispos. 2006 Oct;34(10):1756-63. doi: 10.1124/dmd.106.010033. Epub 2006 Jul 12.
306 The use of genomics technology to investigate gene expression changes in cultured human liver cells. Toxicol In Vitro. 2001 Aug-Oct;15(4-5):399-405. doi: 10.1016/s0887-2333(01)00043-1.
307 Effects of tobacco compounds on gene expression in fetal lung fibroblasts. Environ Toxicol. 2008 Aug;23(4):423-34.
308 Evaluation of a human iPSC-derived BBB model for repeated dose toxicity testing with cyclosporine A as model compound. Toxicol In Vitro. 2021 Jun;73:105112. doi: 10.1016/j.tiv.2021.105112. Epub 2021 Feb 22.
309 Toxicoproteomics reveals an effect of clozapine on autophagy in human liver spheroids. Toxicol Mech Methods. 2023 Jun;33(5):401-410. doi: 10.1080/15376516.2022.2156005. Epub 2022 Dec 19.
310 Antileishmanial drugs cause up-regulation of interferon-gamma receptor 1, not only in the monocytes of visceral leishmaniasis cases but also in cultured THP1 cells. Ann Trop Med Parasitol. 2003 Apr;97(3):245-57. doi: 10.1179/000349803235001714.
311 Tumor necrosis factor-alpha-induced protein 3 as a putative regulator of nuclear factor-kappaB-mediated resistance to O6-alkylating agents in human glioblastomas. J Clin Oncol. 2006 Jan 10;24(2):274-87. doi: 10.1200/JCO.2005.02.9405. Epub 2005 Dec 19.
312 Comparative gene expression analysis of a chronic myelogenous leukemia cell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine kinase inhibitors. Leuk Res. 2007 Nov;31(11):1511-20.
313 Ouabain induces apoptotic cell death in human prostate DU 145 cancer cells through DNA damage and TRAIL pathways. Environ Toxicol. 2019 Dec;34(12):1329-1339. doi: 10.1002/tox.22834. Epub 2019 Aug 21.
314 Disulfiram is a direct and potent inhibitor of human O6-methylguanine-DNA methyltransferase (MGMT) in brain tumor cells and mouse brain and markedly increases the alkylating DNA damage. Carcinogenesis. 2014 Mar;35(3):692-702. doi: 10.1093/carcin/bgt366. Epub 2013 Nov 5.
315 Induction of the DNA repair gene O6-methylguanine-DNA methyltransferase by dexamethasone in glioblastomas. J Neurosurg. 2004 Oct;101(4):659-63. doi: 10.3171/jns.2004.101.4.0659.
316 Phenytoin may increase the efficacy of temozolomide by methylating DNA-repair enzyme, O6-methylguanine-DNA methyltransferase in patients with glioblastoma. Med Hypotheses. 2005;65(4):819-20. doi: 10.1016/j.mehy.2005.04.007.
317 Pharmacokinetic, biochemical and clinical effects of dimethyltriazenoimidazole-4-carboxamide-bischloroethylnitrosourea combination therapy in patients with advanced breast cancer. Int J Cancer. 2003 Feb 20;103(5):686-92. doi: 10.1002/ijc.10849.
318 Transcriptional repression of O6-methylguanine DNA methyltransferase gene rendering cells hypersensitive to N,N'-bis(2-chloroethyl)-N-nitrosurea in camptothecin-resistant cells. Mol Pharmacol. 2008 Aug;74(2):517-26. doi: 10.1124/mol.107.043620. Epub 2008 May 20.
319 G-protein gene 825C>T polymorphism is associated with response to clozapine in Brazilian schizophrenics. Pharmacogenomics. 2008 Oct;9(10):1429-36. doi: 10.2217/14622416.9.10.1429.
320 Proteomic analysis of human adipose tissue after rosiglitazone treatment shows coordinated changes to promote glucose uptake. Obesity (Silver Spring). 2010 Jan;18(1):27-34. doi: 10.1038/oby.2009.208. Epub 2009 Jun 25.
321 Cytosine arabinoside induces ectoderm and inhibits mesoderm expression in human embryonic stem cells during multilineage differentiation. Br J Pharmacol. 2011 Apr;162(8):1743-56.
322 Age-dependent antidepressant pharmacogenomics: polymorphisms of the serotonin transporter and G protein beta3 subunit as predictors of response to fluoxetine and nortriptyline. Int J Neuropsychopharmacol. 2003 Dec;6(4):339-46. doi: 10.1017/S1461145703003663.
323 Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 gene. Pharmacogenet Genomics. 2009 Sep;19(9):730-3. doi: 10.1097/FPC.0b013e3283307cf1.
324 G protein beta3 polymorphism and triptan response in cluster headache. Clin Pharmacol Ther. 2007 Oct;82(4):396-401. doi: 10.1038/sj.clpt.6100159. Epub 2007 Mar 14.
325 Zoledronate dysregulates fatty acid metabolism in renal tubular epithelial cells to induce nephrotoxicity. Arch Toxicol. 2018 Jan;92(1):469-485.
326 Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion. Autophagy. 2018;14(8):1435-1455. doi: 10.1080/15548627.2018.1474314. Epub 2018 Jul 20.
327 Proteomic analysis of antiproliferative effects by treatment of 5-fluorouracil in cervical cancer cells. DNA Cell Biol. 2004 Nov;23(11):769-76.
328 Untargeted Proteomics and Systems-Based Mechanistic Investigation of Artesunate in Human Bronchial Epithelial Cells. Chem Res Toxicol. 2015 Oct 19;28(10):1903-13. doi: 10.1021/acs.chemrestox.5b00105. Epub 2015 Sep 21.
329 Cyclosporine A--induced oxidative stress in human renal mesangial cells: a role for ERK 1/2 MAPK signaling. Toxicol Sci. 2012 Mar;126(1):101-13.
330 Human embryonic stem cell derived hepatocyte-like cells as a tool for in vitro hazard assessment of chemical carcinogenicity. Toxicol Sci. 2011 Dec;124(2):278-90. doi: 10.1093/toxsci/kfr225. Epub 2011 Aug 27.
331 Peripheral blood expression of nuclear factor-kappab-regulated genes is associated with rheumatoid arthritis disease activity and responds differentially to anti-tumor necrosis factor-alpha versus methotrexate. J Rheumatol. 2007 Sep;34(9):1817-22. Epub 2007 Aug 1.
332 Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells. World J Gastroenterol. 2009 Jan 21;15(3):310-20.
333 Mapping the dynamics of Nrf2 antioxidant and NFB inflammatory responses by soft electrophilic chemicals in human liver cells defines the transition from adaptive to adverse responses. Toxicol In Vitro. 2022 Oct;84:105419. doi: 10.1016/j.tiv.2022.105419. Epub 2022 Jun 17.
334 Classification of heavy-metal toxicity by human DNA microarray analysis. Environ Sci Technol. 2007 May 15;41(10):3769-74.
335 The hepatotoxic fluoroquinolone trovafloxacin disturbs TNF- and LPS-induced p65 nuclear translocation in vivo and in vitro. Toxicol Appl Pharmacol. 2020 Mar 15;391:114915. doi: 10.1016/j.taap.2020.114915. Epub 2020 Feb 6.
336 Retinoic acid-induced downmodulation of telomerase activity in human cancer cells. Exp Mol Pathol. 2005 Oct;79(2):108-17.
337 A genome-wide analysis of targets of macrolide antibiotics in mammalian cells. J Biol Chem. 2020 Feb 14;295(7):2057-2067. doi: 10.1074/jbc.RA119.010770. Epub 2020 Jan 8.
338 New insights into BaP-induced toxicity: role of major metabolites in transcriptomics and contribution to hepatocarcinogenesis. Arch Toxicol. 2016 Jun;90(6):1449-58.
339 The RET oncogene is a critical component of transcriptional programs associated with retinoic acid-induced differentiation in neuroblastoma. Mol Cancer Ther. 2007 Apr;6(4):1300-9.
340 Overexpression of protein kinase C-beta1 isoenzyme suppresses indomethacin-induced apoptosis in gastric epithelial cells. Gastroenterology. 2000 Mar;118(3):507-14. doi: 10.1016/s0016-5085(00)70256-3.
341 Treatment with anticancer agents induces dysregulation of specific Wnt signaling pathways in human ovarian luteinized granulosa cells in vitro. Toxicol Sci. 2013 Nov;136(1):183-92. doi: 10.1093/toxsci/kft175. Epub 2013 Aug 16.
342 Progesterone increases csk homologous kinase in HMC-1560 human mast cells and reduces cell proliferation. J Cell Biochem. 2007 Dec 1;102(5):1271-80. doi: 10.1002/jcb.21357.
343 Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating p38 MAPK and p42/44 MAPK. Chem Biol Interact. 2017 Aug 1;273:107-114. doi: 10.1016/j.cbi.2017.06.005. Epub 2017 Jun 7.
344 Sertraline, an antidepressant, induces apoptosis in hepatic cells through the mitogen-activated protein kinase pathway. Toxicol Sci. 2014 Feb;137(2):404-15. doi: 10.1093/toxsci/kft254. Epub 2013 Nov 5.
345 Growth stimulation of human pulmonary adenocarcinoma cells and small airway epithelial cells by beta-carotene via activation of cAMP, PKA, CREB and ERK1/2. Int J Cancer. 2006 Mar 15;118(6):1370-80. doi: 10.1002/ijc.21537.
346 Estrogen and pure antiestrogen fulvestrant (ICI 182 780) augment cell-matrigel adhesion of MCF-7 breast cancer cells through a novel G protein coupled estrogen receptor (GPR30)-to-calpain signaling axis. Toxicol Appl Pharmacol. 2014 Mar 1;275(2):176-81. doi: 10.1016/j.taap.2014.01.005. Epub 2014 Jan 17.
347 Inhibition of activator protein 1 by barbiturates is mediated by differential effects on mitogen-activated protein kinases and the small G proteins ras and rac-1. J Pharmacol Exp Ther. 2004 Dec;311(3):1232-40. doi: 10.1124/jpet.104.071332. Epub 2004 Jul 19.
348 Growth of hormone-dependent MCF-7 breast cancer cells is promoted by constitutive caveolin-1 whose expression is lost in an EGF-R-mediated manner during development of tamoxifen resistance. Breast Cancer Res Treat. 2010 Feb;119(3):575-91. doi: 10.1007/s10549-009-0355-8. Epub 2009 Mar 15.
349 Effect of histamine H1 receptor antagonists on TARC/CCL17 and MDC/CCL22 production from CD14+ cells induced by antigenic stimulation in vitro. Int Arch Allergy Immunol. 2011;155(1):38-51. doi: 10.1159/000318720. Epub 2010 Nov 25.
350 SIRT3 Mediates the Antioxidant Effect of Hydrogen Sulfide in Endothelial Cells. Antioxid Redox Signal. 2016 Feb 20;24(6):329-43. doi: 10.1089/ars.2015.6331. Epub 2015 Nov 10.
351 Downregulation of mitogen-activated protein kinases (MAPKs) in chronic ethanol-induced fatty liver. Toxicol Mech Methods. 2020 Jul;30(6):407-416. doi: 10.1080/15376516.2020.1747126. Epub 2020 Apr 1.
352 A unique mechanism of beta-blocker action: carvedilol stimulates beta-arrestin signaling. Proc Natl Acad Sci U S A. 2007 Oct 16;104(42):16657-62. doi: 10.1073/pnas.0707936104. Epub 2007 Oct 9.
353 The stent-eluting drugs sirolimus and paclitaxel suppress healing of the endothelium by induction of autophagy. Am J Pathol. 2009 Nov;175(5):2226-34.
354 Modulation of apoptosis in HaCaT keratinocytes via differential regulation of ERK signaling pathway by flavonoids. J Biol Chem. 2005 Sep 9;280(36):31498-507. doi: 10.1074/jbc.M505537200. Epub 2005 Jul 13.
355 Myeloid cell differentiation in response to calcitriol for expression CD11b and CD14 is regulated by myeloid zinc finger-1 protein downstream of phosphatidylinositol 3-kinase. J Leukoc Biol. 2008 Aug;84(2):519-28. doi: 10.1189/jlb.1207833. Epub 2008 Jun 17.
356 Proteomic analysis of hepatic effects of phenobarbital in mice with humanized liver. Arch Toxicol. 2022 Oct;96(10):2739-2754. doi: 10.1007/s00204-022-03338-7. Epub 2022 Jul 26.
357 Transcriptional up-regulation of restin by all-trans retinoic acid through STAT1 in cancer cell differentiation process. Biochem Biophys Res Commun. 2006 May 19;343(4):1009-16. doi: 10.1016/j.bbrc.2006.02.176. Epub 2006 Mar 9.
358 Anti-oncogenic and pro-differentiation effects of clorgyline, a monoamine oxidase A inhibitor, on high grade prostate cancer cells. BMC Med Genomics. 2009 Aug 20;2:55. doi: 10.1186/1755-8794-2-55.
359 Gene expression in human hippocampus from cocaine abusers identifies genes which regulate extracellular matrix remodeling. PLoS One. 2007 Nov 14;2(11):e1187. doi: 10.1371/journal.pone.0001187.
360 High-throughput ectopic expression screen for tamoxifen resistance identifies an atypical kinase that blocks autophagy. Proc Natl Acad Sci U S A. 2011 Feb 1;108(5):2058-63.
361 Differential effects of omega-3 and omega-6 Fatty acids on gene expression in breast cancer cells. Breast Cancer Res Treat. 2007 Jan;101(1):7-16. doi: 10.1007/s10549-006-9269-x. Epub 2006 Jul 6.
362 CXCL14 downregulation in human keratinocytes is a potential biomarker for a novel in vitro skin sensitization test. Toxicol Appl Pharmacol. 2020 Jan 1;386:114828. doi: 10.1016/j.taap.2019.114828. Epub 2019 Nov 14.
363 Integrated analysis of rifampicin-induced microRNA and gene expression changes in human hepatocytes. Drug Metab Pharmacokinet. 2014;29(4):333-40.
364 Identification of specific ligands for orphan olfactory receptors. G protein-dependent agonism and antagonism of odorants. J Biol Chem. 2005 Mar 25;280(12):11807-15. doi: 10.1074/jbc.M411508200. Epub 2004 Dec 14.
365 Clinical determinants of response to irinotecan-based therapy derived from cell line models. Clin Cancer Res. 2008 Oct 15;14(20):6647-55.
366 Quantitative proteomics and transcriptomics addressing the estrogen receptor subtype-mediated effects in T47D breast cancer cells exposed to the phytoestrogen genistein. Mol Cell Proteomics. 2011 Jan;10(1):M110.002170.
367 Response rate of fibrosarcoma cells to cytotoxic drugs on the expression level correlates to the therapeutic response rate of fibrosarcomas and is mediated by regulation of apoptotic pathways. BMC Cancer. 2005 Jul 7;5:74. doi: 10.1186/1471-2407-5-74.
368 Synergistic antimetastatic effect of cotreatment with licochalcone A and sorafenib on human hepatocellular carcinoma cells through the inactivation of MKK4/JNK and uPA expression. Environ Toxicol. 2018 Dec;33(12):1237-1244. doi: 10.1002/tox.22630. Epub 2018 Sep 6.
369 [Indomethacin-induced HL-60 leukemic cell apoptosis and the activation of C-jun NH2- terminal kinase signal transduction pathway]. Hunan Yi Ke Da Xue Xue Bao. 2003 Dec;28(6):557-62.
370 Estrogen Regulates MAPK-Related Genes through Genomic and Nongenomic Interactions between IGF-I Receptor Tyrosine Kinase and Estrogen Receptor-Alpha Signaling Pathways in Human Uterine Leiomyoma Cells. J Signal Transduct. 2012;2012:204236. doi: 10.1155/2012/204236. Epub 2012 Oct 9.
371 Identification of potential biomarkers for predicting acute dermal irritation by proteomic analysis. J Appl Toxicol. 2011 Nov;31(8):762-72.
372 Increased mitochondrial ROS formation by acetaminophen in human hepatic cells is associated with gene expression changes suggesting disruption of the mitochondrial electron transport chain. Toxicol Lett. 2015 Apr 16;234(2):139-50.
373 Comparison of quantitation methods in proteomics to define relevant toxicological information on AhR activation of HepG2 cells by BaP. Toxicology. 2021 Jan 30;448:152652. doi: 10.1016/j.tox.2020.152652. Epub 2020 Dec 2.
374 JunD is involved in the antiproliferative effect of Delta9-tetrahydrocannabinol on human breast cancer cells. Oncogene. 2008 Aug 28;27(37):5033-44.
375 Curcumin prevents DNA damage and enhances the repair potential in a chronically arsenic-exposed human population in West Bengal, India. Eur J Cancer Prev. 2011 Mar;20(2):123-31. doi: 10.1097/cej.0b013e328341017a.
376 Nicotinic modulation of gene expression in SH-SY5Y neuroblastoma cells. Brain Res. 2006 Oct 20;1116(1):39-49.
377 Fenfluramine-induced gene dysregulation in human pulmonary artery smooth muscle and endothelial cells. Pulm Circ. 2011 Jul-Sep;1(3):405-18. doi: 10.4103/2045-8932.87310.
378 Resveratrol compounds inhibit human holocarboxylase synthetase and cause a lean phenotype in Drosophila melanogaster. J Nutr Biochem. 2015 Nov;26(11):1379-84. doi: 10.1016/j.jnutbio.2015.07.004. Epub 2015 Jul 26.
379 Chromium(VI) causes down regulation of biotinidase in human bronchial epithelial cells by modifications of histone acetylation. Toxicol Lett. 2011 Aug 28;205(2):140-5. doi: 10.1016/j.toxlet.2011.05.1032. Epub 2011 May 27.
380 Fulvestrant induces resistance by modulating GPER and CDK6 expression: implication of methyltransferases, deacetylases and the hSWI/SNF chromatin remodelling complex. Br J Cancer. 2013 Nov 12;109(10):2751-62. doi: 10.1038/bjc.2013.583. Epub 2013 Oct 29.
381 Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis. Br J Haematol. 2009 Mar;144(5):667-76. doi: 10.1111/j.1365-2141.2008.07504.x. Epub 2008 Nov 20.
382 Transcriptional repression of IKK by p53 in arsenite-induced GADD45 accumulation and apoptosis. Oncogene. 2019 Jan;38(5):731-746. doi: 10.1038/s41388-018-0478-7. Epub 2018 Sep 3.
383 Low-dose Bisphenol A exposure alters the functionality and cellular environment in a human cardiomyocyte model. Environ Pollut. 2023 Oct 15;335:122359. doi: 10.1016/j.envpol.2023.122359. Epub 2023 Aug 9.
384 Azosemide is more potent than bumetanide and various other loop diuretics to inhibit the sodium-potassium-chloride-cotransporter human variants hNKCC1A and hNKCC1B. Sci Rep. 2018 Jun 29;8(1):9877. doi: 10.1038/s41598-018-27995-w.
385 Linalool is a PPARalpha ligand that reduces plasma TG levels and rewires the hepatic transcriptome and plasma metabolome. J Lipid Res. 2014 Jun;55(6):1098-110.
386 Transcriptomic analysis of untreated and drug-treated differentiated HepaRG cells over a 2-week period. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):27-35.
387 A trichostatin A expression signature identified by TempO-Seq targeted whole transcriptome profiling. PLoS One. 2017 May 25;12(5):e0178302. doi: 10.1371/journal.pone.0178302. eCollection 2017.
388 Mechanism of cisplatin proximal tubule toxicity revealed by integrating transcriptomics, proteomics, metabolomics and biokinetics. Toxicol In Vitro. 2015 Dec 25;30(1 Pt A):117-27.
389 Interindividual variation in gene expression responses and metabolite formation in acetaminophen-exposed primary human hepatocytes. Arch Toxicol. 2016 May;90(5):1103-15. doi: 10.1007/s00204-015-1545-2. Epub 2015 Jun 24.
390 Alternatives for the worse: Molecular insights into adverse effects of bisphenol a and substitutes during human adipocyte differentiation. Environ Int. 2021 Nov;156:106730. doi: 10.1016/j.envint.2021.106730. Epub 2021 Jun 27.
391 Role of miRNA in the regulation of cannabidiol-mediated apoptosis in neuroblastoma cells. Oncotarget. 2019 Jan 1;10(1):45-59. doi: 10.18632/oncotarget.26534. eCollection 2019 Jan 1.
392 Astaxanthin protects mesenchymal stem cells from oxidative stress by direct scavenging of free radicals and modulation of cell signaling. Chem Biol Interact. 2021 Jan 5;333:109324. doi: 10.1016/j.cbi.2020.109324. Epub 2020 Nov 17.
393 Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells. Br J Nutr. 2012 Mar;107(6):781-90. doi: 10.1017/S0007114511003631. Epub 2011 Aug 1.
394 Quercetin and Its Fermented Extract as a Potential Inhibitor of Bisphenol A-Exposed HT-29 Colon Cancer Cells' Viability. Int J Mol Sci. 2023 Mar 15;24(6):5604. doi: 10.3390/ijms24065604.
395 Arsenic trioxide inhibits the proliferation of myeloma cell line through notch signaling pathway. Cancer Cell Int. 2013 Mar 13;13(1):25. doi: 10.1186/1475-2867-13-25.
396 Mechanism of thalidomide to enhance cytotoxicity of temozolomide in U251-MG glioma cells in vitro. Chin Med J (Engl). 2009 Jun 5;122(11):1260-6.
397 DNA array analysis of the effects of aspirin on colon cancer cells: involvement of Rac1. Carcinogenesis. 2004 Jul;25(7):1293-8.
398 Statins induce apoptosis in ovarian cancer cells through activation of JNK and enhancement of Bim expression. Cancer Chemother Pharmacol. 2009 May;63(6):997-1005. doi: 10.1007/s00280-008-0830-7. Epub 2008 Sep 3.
399 Niclosamide acts as a new inhibitor of vasculogenic mimicry in oral cancer through upregulation of miR-124 and downregulation of STAT3. Oncol Rep. 2018 Feb;39(2):827-833. doi: 10.3892/or.2017.6146. Epub 2017 Dec 11.
400 Effects of metformin and pioglitazone combination on apoptosis and AMPK/mTOR signaling pathway in human anaplastic thyroid cancer cells. J Biochem Mol Toxicol. 2020 Oct;34(10):e22547. doi: 10.1002/jbt.22547. Epub 2020 Jun 26.
401 Mifepristone induced progesterone withdrawal reveals novel regulatory pathways in human endometrium. Mol Hum Reprod. 2007 Sep;13(9):641-54.
402 Retinoic acid and its 4-oxo metabolites are functionally active in human skin cells in vitro. J Invest Dermatol. 2005 Jul;125(1):143-53.
403 Grouping of histone deacetylase inhibitors and other toxicants disturbing neural crest migration by transcriptional profiling. Neurotoxicology. 2015 Sep;50:56-70.
404 Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS-to-MAP kinase signalling in multiple myeloma cells. Br J Haematol. 2005 Sep;130(6):912-25. doi: 10.1111/j.1365-2141.2005.05696.x.
405 Combination of atorvastatin and celecoxib synergistically induces cell cycle arrest and apoptosis in colon cancer cells. Int J Cancer. 2008 May 1;122(9):2115-24. doi: 10.1002/ijc.23315.
406 In vitro antioxidant and antigenotoxic potentials of 3,5-O-di-galloylquinic acid extracted from Myrtus communis leaves and modulation of cell gene expression by H2O2. J Appl Toxicol. 2012 May;32(5):333-41.
407 Gene expression profiling of early primary biliary cirrhosis: possible insights into the mechanism of action of ursodeoxycholic acid. Liver Int. 2008 Aug;28(7):997-1010. doi: 10.1111/j.1478-3231.2008.01744.x. Epub 2008 Apr 15.
408 La-related Protein 1 (LARP1) Represses Terminal Oligopyrimidine (TOP) mRNA Translation Downstream of mTOR Complex 1 (mTORC1). J Biol Chem. 2015 Jun 26;290(26):15996-6020. doi: 10.1074/jbc.M114.621730. Epub 2015 May 4.
409 Transcriptomic analysis of human primary bronchial epithelial cells after chloropicrin treatment. Chem Res Toxicol. 2015 Oct 19;28(10):1926-35.
410 Quercetin and Cisplatin combined treatment altered cell cycle and mitogen activated protein kinase expressions in malignant mesotelioma cells. BMC Complement Altern Med. 2016 Aug 11;16(1):281. doi: 10.1186/s12906-016-1267-x.
411 Proteomic analysis to identify the cellular responses induced by hydroquinone in human embryonic lung fibroblasts. Toxicol Mech Methods. 2006;16(1):1-6. doi: 10.1080/15376520500191797.
412 Ouabain impairs cell migration, and invasion and alters gene expression of human osteosarcoma U-2 OS cells. Environ Toxicol. 2017 Nov;32(11):2400-2413. doi: 10.1002/tox.22453. Epub 2017 Aug 10.
413 1,25-Dihydroxyvitamin D3 suppresses gene expression of eukaryotic translation initiation factor 2 in human promyelocytic leukemia HL-60 cells. Cell Struct Funct. 2005;30(1):1-6. doi: 10.1247/csf.30.1.
414 Decitabine up-regulates S100A2 expression and synergizes with IFN-gamma to kill uveal melanoma cells. Clin Cancer Res. 2007 Sep 1;13(17):5219-25. doi: 10.1158/1078-0432.CCR-07-0816.
415 Role of microRNAs in senescence and its contribution to peripheral neuropathy in the arsenic exposed population of West Bengal, India. Environ Pollut. 2018 Feb;233:596-603. doi: 10.1016/j.envpol.2017.09.063. Epub 2017 Nov 5.
416 Time series analysis of oxidative stress response patterns in HepG2: a toxicogenomics approach. Toxicology. 2013 Apr 5;306:24-34.
417 Methotrexate modulates folate phenotype and inflammatory profile in EA.hy 926 cells. Eur J Pharmacol. 2014 Jun 5;732:60-7.
418 Riboflavin depletion impairs cell proliferation in adult human duodenum: identification of potential effectors. Dig Dis Sci. 2011 Apr;56(4):1007-19. doi: 10.1007/s10620-010-1374-3. Epub 2010 Sep 17.
419 cDNA microarray analysis of isogenic paclitaxel- and doxorubicin-resistant breast tumor cell lines reveals distinct drug-specific genetic signatures of resistance. Breast Cancer Res Treat. 2006 Mar;96(1):17-39. doi: 10.1007/s10549-005-9026-6. Epub 2005 Dec 2.
420 Benzodithiophenes potentiate differentiation of acute promyelocytic leukemia cells by lowering the threshold for ligand-mediated corepressor/coactivator exchange with retinoic acid receptor alpha and enhancing changes in all-trans-retinoic acid-regulated gene expression. Cancer Res. 2005 Sep 1;65(17):7856-65. doi: 10.1158/0008-5472.CAN-05-1056.
421 Arsenic trioxide initiates ER stress responses, perturbs calcium signalling and promotes apoptosis in human lens epithelial cells. Exp Eye Res. 2007 Dec;85(6):825-35. doi: 10.1016/j.exer.2007.08.018. Epub 2007 Aug 29.
422 Identification of transcriptome signatures and biomarkers specific for potential developmental toxicants inhibiting human neural crest cell migration. Arch Toxicol. 2016 Jan;90(1):159-80.
423 Identification of potential biomarkers of hepatitis B-induced acute liver failure using hepatic cells derived from human skin precursors. Toxicol In Vitro. 2015 Sep;29(6):1231-9. doi: 10.1016/j.tiv.2014.10.012. Epub 2014 Oct 24.
424 Bromodomain-containing protein 4 (BRD4) regulates RNA polymerase II serine 2 phosphorylation in human CD4+ T cells. J Biol Chem. 2012 Dec 14;287(51):43137-55.
425 Cannabidiol Induces Cell Cycle Arrest and Cell Apoptosis in Human Gastric Cancer SGC-7901 Cells. Biomolecules. 2019 Jul 25;9(8):302. doi: 10.3390/biom9080302.
426 Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons. Proc Natl Acad Sci U S A. 2004 Nov 2;101(44):15676-81. doi: 10.1073/pnas.0405155101. Epub 2004 Oct 21.
427 Pro-oxidant induced DNA damage in human lymphoblastoid cells: homeostatic mechanisms of genotoxic tolerance. Toxicol Sci. 2012 Aug;128(2):387-97. doi: 10.1093/toxsci/kfs152. Epub 2012 Apr 26.
428 Multifaceted preventive effects of single agent quercetin on a human prostate adenocarcinoma cell line (PC-3): implications for nutritional transcriptomics and multi-target therapy. Med Oncol. 2011 Dec;28(4):1395-404. doi: 10.1007/s12032-010-9603-3. Epub 2010 Jul 2.
429 An in vitro study on anti-carcinogenic effect of remdesivir in human ovarian cancer cells via generation of reactive oxygen species. Hum Exp Toxicol. 2022 Jan-Dec;41:9603271221089257. doi: 10.1177/09603271221089257.
430 Arsenic trioxide induces apoptosis in NB-4, an acute promyelocytic leukemia cell line, through up-regulation of p73 via suppression of nuclear factor kappa B-mediated inhibition of p73 transcription and prevention of NF-kappaB-mediated induction of XIAP, cIAP2, BCL-XL and survivin. Med Oncol. 2010 Sep;27(3):833-42. doi: 10.1007/s12032-009-9294-9. Epub 2009 Sep 10.
431 Suppression of transforming growth factor beta/smad signaling in keloid-derived fibroblasts by quercetin: implications for the treatment of excessive scars. J Trauma. 2004 Nov;57(5):1032-7. doi: 10.1097/01.ta.0000114087.46566.eb.
432 Resveratrol modifies the expression of apoptotic regulatory proteins and sensitizes non-Hodgkin's lymphoma and multiple myeloma cell lines to paclitaxel-induced apoptosis. Mol Cancer Ther. 2004 Jan;3(1):71-84.
433 Neurokinin-1 receptor (NK1R) inhibition sensitizes APL cells to anti-tumor effect of arsenic trioxide via restriction of NF-B axis: Shedding new light on resistance to Aprepitant. Int J Biochem Cell Biol. 2018 Oct;103:105-114. doi: 10.1016/j.biocel.2018.08.010. Epub 2018 Aug 23.
434 Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice. Int J Cancer. 2008 Aug 15;123(4):951-7. doi: 10.1002/ijc.23593.
435 The antipsychotic chlorpromazine suppresses YAP signaling, stemness properties, and drug resistance in breast cancer cells. Chem Biol Interact. 2019 Apr 1;302:28-35. doi: 10.1016/j.cbi.2019.01.033. Epub 2019 Jan 28.
436 Inhibition of PI3K pathway using BKM120 intensified the chemo-sensitivity of breast cancer cells to arsenic trioxide (ATO). Int J Biochem Cell Biol. 2019 Nov;116:105615. doi: 10.1016/j.biocel.2019.105615. Epub 2019 Sep 17.
437 Etodolac inhibits EBER expression and induces Bcl-2-regulated apoptosis in Burkitt's lymphoma cells. Eur J Haematol. 2005 Sep;75(3):212-20. doi: 10.1111/j.1600-0609.2005.00498.x.
438 Apoptosis induction by 1alpha,25-dihydroxyvitamin D3 in prostate cancer. Mol Cancer Ther. 2002 Jul;1(9):667-77.
439 Retinoic acid receptor alpha amplifications and retinoic acid sensitivity in breast cancers. Clin Breast Cancer. 2013 Oct;13(5):401-8.
440 Differential expression of microRNAs and their predicted targets in renal cells exposed to amphotericin B and its complex with copper (II) ions. Toxicol Mech Methods. 2017 Sep;27(7):537-543. doi: 10.1080/15376516.2017.1333554. Epub 2017 Jun 8.
441 Effects of aspirin on metastasis-associated gene expression detected by cDNA microarray. Acta Pharmacol Sin. 2004 Oct;25(10):1327-33.
442 Identification of novel low-dose bisphenol a targets in human foreskin fibroblast cells derived from hypospadias patients. PLoS One. 2012;7(5):e36711. doi: 10.1371/journal.pone.0036711. Epub 2012 May 4.
443 Zinc and the cytoskeleton in the neuronal modulation of transcription factor NFAT. J Cell Physiol. 2007 Jan;210(1):246-56. doi: 10.1002/jcp.20861.
444 NFATc4 mediates ethanol-triggered hepatocyte senescence. Toxicol Lett. 2021 Oct 10;350:10-21. doi: 10.1016/j.toxlet.2021.06.018. Epub 2021 Jun 27.
445 Constrictor-induced translocation of NFAT3 in human and rat pulmonary artery smooth muscle. Am J Physiol Lung Cell Mol Physiol. 2005 Dec;289(6):L1061-74. doi: 10.1152/ajplung.00096.2005. Epub 2005 Jul 29.
446 Differentiation-associated alteration in gene expression of importins and exportins in human leukemia HL-60 cells. Biomed Res. 2008 Jun;29(3):141-5. doi: 10.2220/biomedres.29.141.
447 Analysis of the transcriptional regulation of cancer-related genes by aberrant DNA methylation of the cis-regulation sites in the promoter region during hepatocyte carcinogenesis caused by arsenic. Oncotarget. 2015 Aug 28;6(25):21493-506. doi: 10.18632/oncotarget.4085.
448 Berberine acts as a putative epigenetic modulator by affecting the histone code. Toxicol In Vitro. 2016 Oct;36:10-17. doi: 10.1016/j.tiv.2016.06.004. Epub 2016 Jun 13.
449 Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line. Nucl Med Biol. 2006 Oct;33(7):875-82. doi: 10.1016/j.nucmedbio.2006.07.004.
450 Ornithine decarboxylase antizyme upregulates DNA-dependent protein kinase and enhances the nonhomologous end-joining repair of DNA double-strand breaks in human oral cancer cells. Biochemistry. 2007 Aug 7;46(31):8920-32. doi: 10.1021/bi7000328. Epub 2007 Jul 14.
451 Endoplasmic reticulum stress impairs insulin signaling through mitochondrial damage in SH-SY5Y cells. Neurosignals. 2012;20(4):265-80.
452 Transcriptome and DNA methylation changes modulated by sulforaphane induce cell cycle arrest, apoptosis, DNA damage, and suppression of proliferation in human liver cancer cells. Food Chem Toxicol. 2020 Feb;136:111047. doi: 10.1016/j.fct.2019.111047. Epub 2019 Dec 12.
453 Persistent and non-persistent changes in gene expression result from long-term estrogen exposure of MCF-7 breast cancer cells. J Steroid Biochem Mol Biol. 2011 Feb;123(3-5):140-50.
454 The induction of cytochrome P450 2E1 by ethanol leads to the loss of synaptic proteins via PPARalpha down-regulation. Toxicology. 2017 Jun 15;385:18-27.
455 Cannabidiol-induced transcriptomic changes and cellular senescence in human Sertoli cells. Toxicol Sci. 2023 Feb 17;191(2):227-238. doi: 10.1093/toxsci/kfac131.
456 Systems analysis of transcriptome and proteome in retinoic acid/arsenic trioxide-induced cell differentiation/apoptosis of promyelocytic leukemia. Proc Natl Acad Sci U S A. 2005 May 24;102(21):7653-8.
457 In vitro and in vivo effects of the PPAR-alpha agonists fenofibrate and retinoic acid in endometrial cancer. Mol Cancer. 2006 Mar 28;5:13.
458 Gene expression signatures after ethanol exposure in differentiating embryoid bodies. Toxicol In Vitro. 2018 Feb;46:66-76.
459 Synergistic effect of JQ1 and rapamycin for treatment of human osteosarcoma. Int J Cancer. 2015 May 1;136(9):2055-64.
460 Bisphenol A induces DSB-ATM-p53 signaling leading to cell cycle arrest, senescence, autophagy, stress response, and estrogen release in human fetal lung fibroblasts. Arch Toxicol. 2018 Apr;92(4):1453-1469.
461 Epigenetic changes in individuals with arsenicosis. Chem Res Toxicol. 2011 Feb 18;24(2):165-7. doi: 10.1021/tx1004419. Epub 2011 Feb 4.
462 Gene expression profile analysis of 4-phenylbutyrate treatment of IB3-1 bronchial epithelial cell line demonstrates a major influence on heat-shock proteins. Physiol Genomics. 2004 Jan 15;16(2):204-11.
463 Transcriptional signature of human macrophages exposed to the environmental contaminant benzo(a)pyrene. Toxicol Sci. 2010 Apr;114(2):247-59.
464 Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. Cancer Res. 2023 Jan 18;83(2):181-194. doi: 10.1158/0008-5472.CAN-22-1029.
465 Targeting MYC dependence in cancer by inhibiting BET bromodomains. Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):16669-74. doi: 10.1073/pnas.1108190108. Epub 2011 Sep 26.
466 Comparative proteomics reveals concordant and discordant biochemical effects of caffeine versus epigallocatechin-3-gallate in human endothelial cells. Toxicol Appl Pharmacol. 2019 Sep 1;378:114621. doi: 10.1016/j.taap.2019.114621. Epub 2019 Jun 10.
467 Comprehensive analysis of transcriptomic changes induced by low and high doses of bisphenol A in HepG2 spheroids in vitro and rat liver in vivo. Environ Res. 2019 Jun;173:124-134. doi: 10.1016/j.envres.2019.03.035. Epub 2019 Mar 18.
468 Stem cell transcriptome responses and corresponding biomarkers that indicate the transition from adaptive responses to cytotoxicity. Chem Res Toxicol. 2017 Apr 17;30(4):905-922.
469 Down-regulation of ALKBH2 increases cisplatin sensitivity in H1299 lung cancer cells. Acta Pharmacol Sin. 2011 Mar;32(3):393-8. doi: 10.1038/aps.2010.216. Epub 2011 Jan 31.
470 A transcriptomics-based in vitro assay for predicting chemical genotoxicity in vivo. Carcinogenesis. 2012 Jul;33(7):1421-9.
471 Pharmacogenomic identification of novel determinants of response to chemotherapy in colon cancer. Cancer Res. 2006 Mar 1;66(5):2765-77.
472 Elevated expression of TMEM205, a hypothetical membrane protein, is associated with cisplatin resistance. J Cell Physiol. 2010 Nov;225(3):822-8. doi: 10.1002/jcp.22287.
473 Dihydroceramide accumulation mediates cytotoxic autophagy of cancer cells via autolysosome destabilization. Autophagy. 2016 Nov;12(11):2213-2229. doi: 10.1080/15548627.2016.1213927. Epub 2016 Sep 16.
474 Effects of progesterone treatment on expression of genes involved in uterine quiescence. Reprod Sci. 2011 Aug;18(8):781-97.
475 Isobaric tags for relative and absolute quantitation-based proteomics analysis of the effect of ginger oil on bisphenol A-induced breast cancer cell proliferation. Oncol Lett. 2021 Feb;21(2):101. doi: 10.3892/ol.2020.12362. Epub 2020 Dec 8.
476 DNA Methylome Analysis of Saturated Aliphatic Aldehydes in Pulmonary Toxicity. Sci Rep. 2018 Jul 12;8(1):10497. doi: 10.1038/s41598-018-28813-z.
477 Benzo[a]pyrene-induced changes in microRNA-mRNA networks. Chem Res Toxicol. 2012 Apr 16;25(4):838-49.
478 Integrated 'omics analysis reveals new drug-induced mitochondrial perturbations in human hepatocytes. Toxicol Lett. 2018 Jun 1;289:1-13.
479 BET bromodomain inhibition as a novel strategy for reactivation of HIV-1. J Leukoc Biol. 2012 Dec;92(6):1147-54. doi: 10.1189/jlb.0312165. Epub 2012 Jul 16.
480 A human Na+/H+ antiporter sharing evolutionary origins with bacterial NhaA may be a candidate gene for essential hypertension. Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18677-81. doi: 10.1073/pnas.0707120104. Epub 2007 Nov 13.
481 Soy isoflavones exert differential effects on androgen responsive genes in LNCaP human prostate cancer cells. J Nutr. 2007 Apr;137(4):964-72.
482 The marine toxin okadaic acid induces alterations in the expression level of cancer-related genes in human neuronal cells. Ecotoxicol Environ Saf. 2013 Jun;92:303-11. doi: 10.1016/j.ecoenv.2013.03.009. Epub 2013 Apr 3.
483 Inhibiting Heat Shock Proteins Can Potentiate the Cytotoxic Effect of Cannabidiol in Human Glioma Cells. Anticancer Res. 2015 Nov;35(11):5827-37.
484 A genomic approach to predict synergistic combinations for breast cancer treatment. Pharmacogenomics J. 2013 Feb;13(1):94-104. doi: 10.1038/tpj.2011.48. Epub 2011 Nov 15.
485 ON 01910.Na is selectively cytotoxic for chronic lymphocytic leukemia cells through a dual mechanism of action involving PI3K/AKT inhibition and induction of oxidative stress. Clin Cancer Res. 2012 Apr 1;18(7):1979-91. doi: 10.1158/1078-0432.CCR-11-2113. Epub 2012 Feb 20.
486 Dose- and time-dependent effects of phenobarbital on gene expression profiling in human hepatoma HepaRG cells. Toxicol Appl Pharmacol. 2009 Feb 1;234(3):345-60.
487 The molecular basis of genistein-induced mitotic arrest and exit of self-renewal in embryonal carcinoma and primary cancer cell lines. BMC Med Genomics. 2008 Oct 10;1:49.
488 Dasatinib reverses cancer-associated fibroblasts (CAFs) from primary lung carcinomas to a phenotype comparable to that of normal fibroblasts. Mol Cancer. 2010 Jun 27;9:168.
489 Regulation of gene expression and inhibition of experimental prostate cancer bone metastasis by dietary genistein. Neoplasia. 2004 Jul-Aug;6(4):354-63. doi: 10.1593/neo.03478.
490 Differently expressed long noncoding RNAs and mRNAs in TK6 cells exposed to low dose hydroquinone. Oncotarget. 2017 Oct 4;8(56):95554-95567. doi: 10.18632/oncotarget.21481. eCollection 2017 Nov 10.
491 Comparative Analysis of Transcriptomic Changes including mRNA and microRNA Expression Induced by the Xenoestrogens Zearalenone and Bisphenol A in Human Ovarian Cells. Toxins (Basel). 2023 Feb 9;15(2):140. doi: 10.3390/toxins15020140.
492 Endometrial receptivity is affected in women with high circulating progesterone levels at the end of the follicular phase: a functional genomics analysis. Hum Reprod. 2011 Jul;26(7):1813-25.
493 Effects of lithium and valproic acid on gene expression and phenotypic markers in an NT2 neurosphere model of neural development. PLoS One. 2013;8(3):e58822.
494 Functional lipidomics: Palmitic acid impairs hepatocellular carcinoma development by modulating membrane fluidity and glucose metabolism. Hepatology. 2017 Aug;66(2):432-448. doi: 10.1002/hep.29033. Epub 2017 Jun 16.
495 Prediction of doxorubicin sensitivity in breast tumors based on gene expression profiles of drug-resistant cell lines correlates with patient survival. Oncogene. 2005 Nov 17;24(51):7542-51. doi: 10.1038/sj.onc.1208908.
496 Linking site-specific loss of histone acetylation to repression of gene expression by the mycotoxin ochratoxin A. Arch Toxicol. 2018 Feb;92(2):995-1014.
497 Delta9-tetrahydrocannabinol inhibits cytotrophoblast cell proliferation and modulates gene transcription. Mol Hum Reprod. 2006 May;12(5):321-33. doi: 10.1093/molehr/gal036. Epub 2006 Apr 5.
498 Nicotine modulates the expression of a diverse set of genes in the neuronal SH-SY5Y cell line. J Biol Chem. 2003 May 2;278(18):15633-40.
499 Alcohol triggered bile acid disequilibrium by suppressing BSEP to sustain hepatocellular carcinoma progression. Chem Biol Interact. 2022 Apr 1;356:109847. doi: 10.1016/j.cbi.2022.109847. Epub 2022 Feb 9.
500 Genome-Wide Analysis of Low Dose Bisphenol-A (BPA) Exposure in Human Prostate Cells. Curr Genomics. 2019 May;20(4):260-274. doi: 10.2174/1389202920666190603123040.
501 Ultradian cortisol pulsatility encodes a distinct, biologically important signal. PLoS One. 2011 Jan 18;6(1):e15766.
502 Chromatin modifiers: A new class of pollutants with potential epigenetic effects revealed by in vitro assays and transcriptomic analyses. Toxicology. 2023 Jan 15;484:153413. doi: 10.1016/j.tox.2022.153413. Epub 2022 Dec 26.
503 Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma. Head Neck. 2011 Jul;33(7):959-68. doi: 10.1002/hed.21559. Epub 2010 Aug 24.
504 Expression of copper-responsive genes in HepG2 cells. Mol Cell Biochem. 2005 Nov;279(1-2):141-7.
505 Synergistic effects of arsenic trioxide combined with ascorbic acid in human osteosarcoma MG-63 cells: a systems biology analysis. Eur Rev Med Pharmacol Sci. 2014;18(24):3877-88.
506 Drinking-water arsenic exposure modulates gene expression in human lymphocytes from a U.S. population. Environ Health Perspect. 2008 Apr;116(4):524-31. doi: 10.1289/ehp.10861.
507 miR-148a/LDLR mediates hypercholesterolemia induced by prenatal dexamethasone exposure in male offspring rats. Toxicol Appl Pharmacol. 2020 May 15;395:114979. doi: 10.1016/j.taap.2020.114979. Epub 2020 Mar 29.
508 Protein profile in neuroblastoma cells incubated with S- and R-enantiomers of ibuprofen by iTRAQ-coupled 2-D LC-MS/MS analysis: possible action of induced proteins on Alzheimer's disease. Proteomics. 2008 Apr;8(8):1595-607. doi: 10.1002/pmic.200700556.
509 Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies. Leuk Res. 2008 Feb;32(2):275-85. doi: 10.1016/j.leukres.2007.05.024. Epub 2007 Jul 19.
510 Comparison of the gene expression profiles of monocytic versus granulocytic lineages of HL-60 leukemia cell differentiation by DNA microarray analysis. Life Sci. 2003 Aug 15;73(13):1705-19. doi: 10.1016/s0024-3205(03)00515-0.
511 Genome-wide alteration in DNA hydroxymethylation in the sperm from bisphenol A-exposed men. PLoS One. 2017 Jun 5;12(6):e0178535. doi: 10.1371/journal.pone.0178535. eCollection 2017.
512 Monitoring of deiodinase deficiency based on transcriptomic responses in SH-SY5Y cells. Arch Toxicol. 2013 Jun;87(6):1103-13. doi: 10.1007/s00204-013-1018-4. Epub 2013 Feb 10.
513 Arsenic alters transcriptional responses to Pseudomonas aeruginosa infection and decreases antimicrobial defense of human airway epithelial cells. Toxicol Appl Pharmacol. 2017 Sep 15;331:154-163.
514 Specific Inhibition of NEIL-initiated repair of oxidized base damage in human genome by copper and iron: potential etiological linkage to neurodegenerative diseases. J Biol Chem. 2010 Sep 10;285(37):28812-25. doi: 10.1074/jbc.M110.126664. Epub 2010 Jul 9.
515 Chemical stresses fail to mimic the unfolded protein response resulting from luminal load with unfolded polypeptides. J Biol Chem. 2018 Apr 13;293(15):5600-5612.
516 Gene-expression profiling during curcumin-induced apoptosis reveals downregulation of CXCR4. Exp Hematol. 2007 Jan;35(1):84-95.
517 Cellular response to 5-fluorouracil (5-FU) in 5-FU-resistant colon cancer cell lines during treatment and recovery. Mol Cancer. 2006 May 18;5:20. doi: 10.1186/1476-4598-5-20.
518 Folic acid induces cell type-specific changes in the transcriptome of breast cancer cell lines: a proof-of-concept study. J Nutr Sci. 2016 Apr 26;5:e17. doi: 10.1017/jns.2016.8. eCollection 2016.
519 Novel ATP-competitive Akt inhibitor afuresertib suppresses the proliferation of malignant pleural mesothelioma cells. Cancer Med. 2017 Nov;6(11):2646-2659. doi: 10.1002/cam4.1179. Epub 2017 Sep 27.
520 Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors. Mol Cell. 2006 Nov 3;24(3):341-54. doi: 10.1016/j.molcel.2006.10.019.
521 Hydrocortisone enhances the barrier properties of HBMEC/ci, a brain microvascular endothelial cell line, through mesenchymal-to-endothelial transition-like effects. Fluids Barriers CNS. 2015 Mar 5;12:7. doi: 10.1186/s12987-015-0003-0. eCollection 2015.
522 Cdk4/6 inhibition induces epithelial-mesenchymal transition and enhances invasiveness in pancreatic cancer cells. Mol Cancer Ther. 2012 Oct;11(10):2138-48. doi: 10.1158/1535-7163.MCT-12-0562. Epub 2012 Aug 6.
523 Expression Profiling of Human Pluripotent Stem Cell-Derived Cardiomyocytes Exposed to Doxorubicin-Integration and Visualization of Multi-Omics Data. Toxicol Sci. 2018 May 1;163(1):182-195. doi: 10.1093/toxsci/kfy012.
524 Changes in gene expressions elicited by physiological concentrations of genistein on human endometrial cancer cells. Mol Carcinog. 2006 Oct;45(10):752-63.
525 Gene expression profiling in Ishikawa cells: a fingerprint for estrogen active compounds. Toxicol Appl Pharmacol. 2009 Apr 1;236(1):85-96.
526 Transcriptional activation of TINF2, a gene encoding the telomere-associated protein TIN2, by Sp1 and NF-B factors. PLoS One. 2011;6(6):e21333. doi: 10.1371/journal.pone.0021333. Epub 2011 Jun 23.
527 Evidence for a role of claudin 2 as a proximal tubular stress responsive paracellular water channel. Toxicol Appl Pharmacol. 2014 Sep 1;279(2):163-72.
528 Distinctive profiles of gene expression in the human nucleus accumbens associated with cocaine and heroin abuse. Neuropsychopharmacology. 2006 Oct;31(10):2304-12. doi: 10.1038/sj.npp.1301089. Epub 2006 May 3.
529 Multi-level gene expression profiles affected by thymidylate synthase and 5-fluorouracil in colon cancer. BMC Genomics. 2006 Apr 3;7:68. doi: 10.1186/1471-2164-7-68.
530 Effects of folate deficiency on gene expression in the apoptosis and cancer pathways in colon cancer cells. Carcinogenesis. 2006 May;27(5):916-24. doi: 10.1093/carcin/bgi312. Epub 2005 Dec 16.
531 Molecular mechanism of action of bisphenol and bisphenol A mediated by oestrogen receptor alpha in growth and apoptosis of breast cancer cells. Br J Pharmacol. 2013 May;169(1):167-78.
532 Marine biogenics in sea spray aerosols interact with the mTOR signaling pathway. Sci Rep. 2019 Jan 24;9(1):675.
533 Folate deficiency in normal human fibroblasts leads to altered expression of genes primarily linked to cell signaling, the cytoskeleton and extracellular matrix. J Nutr Biochem. 2007 Aug;18(8):541-52. doi: 10.1016/j.jnutbio.2006.11.002. Epub 2007 Feb 22.
534 Loss of TRIM33 causes resistance to BET bromodomain inhibitors through MYC- and TGF-beta-dependent mechanisms. Proc Natl Acad Sci U S A. 2016 Aug 2;113(31):E4558-66.
535 Dose- and time-dependent transcriptional response of Ishikawa cells exposed to genistein. Toxicol Sci. 2016 May;151(1):71-87.
536 Improved apoptotic cell death in drug-resistant non-small-cell lung cancer cells by tumor necrosis factor-related apoptosis-inducing ligand-based treatment. J Pharmacol Exp Ther. 2014 Mar;348(3):360-71. doi: 10.1124/jpet.113.210054. Epub 2013 Dec 17.
537 Anti-proliferative and gene expression actions of resveratrol in breast cancer cells in vitro. Oncotarget. 2014 Dec 30;5(24):12891-907.
538 AMPK activation induced by promethazine increases NOXA expression and Beclin-1 phosphorylation and drives autophagy-associated apoptosis in chronic myeloid leukemia. Chem Biol Interact. 2020 Jan 5;315:108888. doi: 10.1016/j.cbi.2019.108888. Epub 2019 Nov 2.
539 shRNA-mediated AMBRA1 knockdown reduces the cisplatin-induced autophagy and sensitizes ovarian cancer cells to cisplatin. J Toxicol Sci. 2016 Feb;41(1):45-53. doi: 10.2131/jts.41.45.
540 Simvastatin inactivates beta1-integrin and extracellular signal-related kinase signaling and inhibits cell proliferation in head and neck squamous cell carcinoma cells. Cancer Sci. 2007 Jun;98(6):890-9.
541 New insights into the mechanisms underlying 5-fluorouracil-induced intestinal toxicity based on transcriptomic and metabolomic responses in human intestinal organoids. Arch Toxicol. 2021 Aug;95(8):2691-2718. doi: 10.1007/s00204-021-03092-2. Epub 2021 Jun 20.
542 Robustness testing and optimization of an adverse outcome pathway on cholestatic liver injury. Arch Toxicol. 2020 Apr;94(4):1151-1172. doi: 10.1007/s00204-020-02691-9. Epub 2020 Mar 10.
543 Down-regulation of CYLD as a trigger for NF-B activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cells. Int J Oncol. 2011 Jan;38(1):121-31.
544 Comparative DNA microarray analysis of human monocyte derived dendritic cells and MUTZ-3 cells exposed to the moderate skin sensitizer cinnamaldehyde. Toxicol Appl Pharmacol. 2009 Sep 15;239(3):273-83.
545 Effect of prenatal arsenic exposure on DNA methylation and leukocyte subpopulations in cord blood. Epigenetics. 2014 May;9(5):774-82. doi: 10.4161/epi.28153. Epub 2014 Feb 13.
546 Growth-suppressive effect of non-steroidal anti-inflammatory drugs on 11 colon-cancer cell lines and fluorescence differential display of genes whose expression is influenced by sulindac. Int J Cancer. 2000 Dec 15;88(6):873-80. doi: 10.1002/1097-0215(20001215)88:6<873::aid-ijc6>3.0.co;2-b.
547 Identification of novel biomarkers for doxorubicin-induced toxicity in human cardiomyocytes derived from pluripotent stem cells. Toxicology. 2015 Feb 3;328:102-11. doi: 10.1016/j.tox.2014.12.018. Epub 2014 Dec 18.
548 Transcriptional responses to estrogen and progesterone in mammary gland identify networks regulating p53 activity. Endocrinology. 2008 Oct;149(10):4809-20. doi: 10.1210/en.2008-0035. Epub 2008 Jun 12.
549 Beta-carotene and apocarotenals promote retinoid signaling in BEAS-2B human bronchioepithelial cells. Arch Biochem Biophys. 2006 Nov 1;455(1):48-60.
550 Gene expression profile induced by arsenic trioxide in chronic lymphocytic leukemia cells reveals a central role for heme oxygenase-1 in apoptosis and regulation of matrix metalloproteinase-9. Oncotarget. 2016 Dec 13;7(50):83359-83377.
551 Gene expression profile of colon cancer cell lines treated with SN-38. Chemotherapy. 2010;56(1):17-25. doi: 10.1159/000287353. Epub 2010 Feb 24.
552 Agonist and antagonist of retinoic acid receptors cause similar changes in gene expression and induce senescence-like growth arrest in MCF-7 breast carcinoma cells. Cancer Res. 2006 Sep 1;66(17):8749-61.
553 Influence of Iron on Cytotoxicity and Gene Expression Profiles Induced by Arsenic in HepG2 Cells. Int J Environ Res Public Health. 2019 Nov 14;16(22):4484. doi: 10.3390/ijerph16224484.
554 Promoter CpG island hypermethylation- and H3K9me3 and H3K27me3-mediated epigenetic silencing targets the deleted in colon cancer (DCC) gene in colorectal carcinogenesis without affecting neighboring genes on chromosomal region 18q21. Carcinogenesis. 2009 Jun;30(6):1041-8. doi: 10.1093/carcin/bgp073. Epub 2009 Mar 27.
555 Effects of chronic exposure to arsenic and estrogen on epigenetic regulatory genes expression and epigenetic code in human prostate epithelial cells. PLoS One. 2012;7(8):e43880. doi: 10.1371/journal.pone.0043880. Epub 2012 Aug 27.
556 Sex hormones and gene expression signatures in peripheral blood from postmenopausal women - the NOWAC postgenome study. BMC Med Genomics. 2011 Mar 31;4:29. doi: 10.1186/1755-8794-4-29.
557 Hydroquinone triggers pyroptosis and endoplasmic reticulum stress via AhR-regulated oxidative stress in human lymphocytes. Toxicol Lett. 2023 Mar 1;376:39-50. doi: 10.1016/j.toxlet.2023.01.005. Epub 2023 Jan 13.
558 Ethanol directly induced HMGB1 release through NOX2/NLRP1 inflammasome in neuronal cells. Toxicology. 2015 Aug 6;334:104-10. doi: 10.1016/j.tox.2015.06.006. Epub 2015 Jun 12.
559 Preferential induction of the AhR gene battery in HepaRG cells after a single or repeated exposure to heterocyclic aromatic amines. Toxicol Appl Pharmacol. 2010 Nov 15;249(1):91-100.
560 Dissecting progressive stages of 5-fluorouracil resistance in vitro using RNA expression profiling. Int J Cancer. 2004 Nov 1;112(2):200-12. doi: 10.1002/ijc.20401.
561 Benzo[a]pyrene increases the Nrf2 content by downregulating the Keap1 message. Toxicol Sci. 2010 Aug;116(2):549-61.
562 Analysis of the prostate cancer cell line LNCaP transcriptome using a sequencing-by-synthesis approach. BMC Genomics. 2006 Sep 29;7:246. doi: 10.1186/1471-2164-7-246.
563 Gene expression profile and cytotoxicity of human bronchial epithelial cells exposed to crotonaldehyde. Toxicol Lett. 2010 Aug 16;197(2):113-22.
564 The DNA methyltransferase inhibitors azacitidine, decitabine and zebularine exert differential effects on cancer gene expression in acute myeloid leukemia cells. Leukemia. 2009 Jun;23(6):1019-28.
565 Changes in gene expression profiles of multiple myeloma cells induced by arsenic trioxide (ATO): possible mechanisms to explain ATO resistance in vivo. Br J Haematol. 2005 Mar;128(5):636-44.
566 Differentially expressed genes in the prostate cancer cell line LNCaP after exposure to androgen and anti-androgen. Cancer Genet Cytogenet. 2006 Apr 15;166(2):130-8. doi: 10.1016/j.cancergencyto.2005.09.012.
567 Bisphenol A and bisphenol S induce distinct transcriptional profiles in differentiating human primary preadipocytes. PLoS One. 2016 Sep 29;11(9):e0163318.